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Abstract
Nosocomial infections are a cause of concern for hospital patients and the incidence rates of
these infections are greater in intensive care units (ICUs) due to the invasive nature of
treatments, additional risk factors and comorbidities, and therapies used. Invasive devices, such
as vascular central lines, Foley catheters, and mechanical ventilators pose a risk for critically ill
patients in the ICUs to develop device-related, healthcare-associated infections (HAI). The
purpose of this study was to describe the epidemiological characteristics of patients who
developed device-related HAIs within 3 ICU units (medical-surgical, cardiovascular, and
neurosurgical) of an academic medical facility. The ecosocial theory of disease distribution
provided the theoretical framework for the study to describe how ecological and social
determinants interact and affect health variances. Secondary data were analyzed using analysis of
variance (ANOVA), Pearson correlations, and chi-square statistical tests. A total of 4,213
patients admitted to the 3 ICUs from 2010-2014 were identified. According to the chi-square
analysis, there was significant association between race/ethnicity and type of device-associated
infection; between gender and types of infection; and between risk factors (diabetes, obesity,
smoking habits) and kinds of infection, all of which the statistical significance had varied for
each individual ICU. Bacterial differences were noted between device-associated infections. The
potential positive social change from this study could be insight on possible new processes and
interventions to reduce nosocomial infections and improve adult ICU patient outcomes such as
decreased HAIs, decreased length of stay, comorbidities, and cost for both the patient and the
hospital.
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Chapter 1: Introduction to the Study
Introduction
Nosocomial infections pose a threat to intensive care unit (ICU) patients and are a cause
of increased morbidity, mortality, length of stay, and cost of care (Marschall et al., 2014).
According to Septimus et al. (2014), healthcare-associated infections are the fifth leading cause
of death in acute care hospitals with a 15% development of infection while in the hospital.
Despite ICU populations being relatively small, compared to nonintensive care units, the
incidence rate of hospital-acquired infections is greater in intensive care units. This is primarily
due to the invasive nature of the treatments and multiple therapies used in ICUs, such as
mechanical ventilation, central venous catheters, pulmonary artery, and urinary catheterization
(DePalo et al., 2010). In addition to invasive therapies and treatments, ICU patients typically
have additional risk factors and comorbidities associated with developing nosocomial infection.
Invasive devices such as vascular central lines, Foley catheters, and ventilators pose a threat to
the critically ill and often immunocompromised ICU patient population, resulting in a greater
risk of developing device-associated nosocomial infections (Marschall et al., 2014). Healthcareassociated infections (HAIs) are problematic in the United States causing a burden to hospitals,
patients, family members, and society in general (Scott, 2009; Umscheid et al., 2011). A
historical, quantitative study was designed to identify and describe the epidemiological
characteristics of ICU patients who developed device associated infections in three different ICU
settings in a large acute care teaching hospital. The findings from this study may offer an
opportunity for healthcare systems to promote positive social change by supporting preventive
techniques related to patient care that may contribute to the elimination of HAIs and improve
patient outcomes. The study may help provide a better understanding of the pathogenesis of
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HAIs by developing strategies or interventions that may aid in the prevention processes to
prevent nosocomial infections.
Background
Obtaining and maintaining reliable vascular access has become one of the most essential
features of medical care. However, during hospitalization, any patient who is admitted to an
intensive care unit and has a central venous catheterization placed will have a higher chance of
acquiring a primary bloodstream infection, which increases the chances of morbidity and
mortality (Blot, Bergs, Vogelaers, Blot, & Vandijck, 2014; Olaechea et al., 2013). According to
the Centers for Disease Control and Prevention (CDC, 2016), there has been progress in reducing
HAIs; however, there is still further action needed at every level of public health to eliminate
infections that are potential threats to each patient admitted into an acute care facility (CDC,
2016).
It was estimated that nearly 40% of all healthcare associated bacteremias are derived
from vascular access (Crnich & Maki, 2009). It was also estimated that more than 250,000
intravascular, device-associated bloodstream infections occur in the United States each year
(Crnich & Maki, 2009). These infections are associated with increased length of hospital stay,
excess healthcare costs, and increased chances of morbidity and mortality (CDC, 2016; Olaechea
et al., 2013; Zimlichman et al., 2013). In a meta-analysis study of costs and financial impact of
HAIs, inflated to 2012 U.S. dollars, it was estimated that the annual costs for major infections
(CLABSI, CAUTI, VAP, MRSA, Clostridium difficile) in adult care facilities were between $8.3
to $11.5 billion (Zimlichman et al., 2013). Furthermore, scholars who included all hospital
acquired infections and pediatrics population estimated that the cost of HAIs in the U.S.
healthcare system range from $28 billion to $45 billion per year (Scott, 2009). There are several
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sources of intravascular, device-associated bloodstream infections that play a role in producing
infections. Two contributors include colonization of the intravascular device and contamination
of the fluid that is being administered through the device (Marschall et al., 2014). It is important
that best practices such as aseptic techniques and infection prevention practices take place during
any hospital stay. Factors associated with increased risks of central line-associated bloodstream
infections include prolonged hospitalization; severity of the illness; and clinical states such as
HIV, neutropenic patients, and any similar condition or illness (Lukenbill et al., 2013).
Additional factors that contribute to the increase of central line bloodstream infections include
insertion and maintenance of the lines (O’Grady et al., 2011). Even though, there are currently
guidelines/bundles for HAI prevention, optimizing quality improvement processes and
standardization of care provide potential benefits to the well-being of ICU patients (PerezGranda, Guembe, Rincón, Muñoz, & Bouza, 2015). The findings from this research may provide
knowledge for clinicians to improve existing preventive guidelines (The Joint Commission,
2013), such as an educational initiative in addition to the bloodstream bundle set that could be
used to help improve central venous catheter insertion and reduce the rate of primary
bloodstream infections.
Problem Statement
Critically ill patients have a significant risk of acquiring infections related to healthcare.
Nosocomial infections that are device-related are considered a standard threat to a patient’s
wellbeing in the intensive care unit and are considered to be a cause of patient morbidity and
mortality (Chen, Wang, Liu, & Chou, 2009). The use of invasive devices is a danger to the safety
of each patient and a potential health risk for patients because it increases the possibility of these
patients acquiring a HAI (Lukenbill et al., 2013). These types of infections can be linked with
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extended hospital stays, sustained costs, and correlated with higher number of comorbidities
(Chen et al., 2009). Patients with multiple risk factors have a higher incidence rate of developing
a central-line bloodstream infection (CLABSI), catheter-associated urinary tract infections
(CAUTI), and ventilator associated pneumonias (VAP), (Chen et. al., 2009; Elpern et al., 2009;
Ong et al., 2011; Clarke et al., 2013). According to Barnett, Graves, Rosenthal, and Salomao
(2010), vascular access causes risks for a patient to develop a central line bloodstream infection.
It was estimated that approximately 60% of all types of HAI bloodstream infections derive from
vascular access (Barnett et al., 2010). Any patient who develops a central line bloodstream
infection while in the ICU is inclined to stay longer in the ICU. The length of stay for an ICU
patient with a bacteremia is estimated to be 3 to 48.5 days (Barnett et al., 2010). Despite multiple
interventions and increased attention directed to identification and prevention of CLABSIs,
CAUTI, and VAPs, there continues to be ongoing occurrences of these healthcare device-related
infections that patients can succumb to during their hospitalization.
According to the literature, there is a gap in clinical practices between interventions and
attention focused on minimizing these infections and actual success at completely eliminating
them (Cardo et al., 2010; Saint et al., 2008). Additional gaps in practice include determining
differences in the types of microorganisms and understanding these pathogens in order to
optimize diagnosis, prevention, and treatment of HAIs. It was the intent of this research study to
address these identified gaps in the literature. By identifying the types of microorganisms most
likely to be involved with device associated healthcare infections, the knowledge base for future
prevention and treatment of these infections in the adult ICU populations may increase.
Additionally, even though scholars (Callister, Limchaiyawat, Eells, & Miller, 2015) have proven
care bundles to reduce CLABSI, device-associated infections are still prevalent in U.S. hospitals.

5

Therefore, looking at risk factors such as the ones in this study can provide additional
information that may be beneficial for developing other preventive tools in the future. The
answers to the research questions may provide a broader base of information to address the gaps
in future research. The existence and continuing evolution of multidrug resistant organisms may
necessitate adaptations to current approaches in order to help prevent HAIs. Further components
for clinical practices and interventions include understanding human factors that may play a role
in implementing appropriate interventions to minimize device-related infections.
Due to there are diverse risk factors including comorbidities associated with different
ICU patient populations (Table 1), historical analysis and comparison of three varied ICU patient
populations and the nosocomial infections encountered may provide insight to more
comprehensive interventions and more accommodations required to minimize CLABSIs,
CAUTIs, and VAPs in an explicit ICU type. The teaching institution at which this study was
conducted had implemented various interventions to help reduce the number of HAIs, but has
unsuccessfully been able to accomplish this goal. Patients in each intensive care unit may have
different risk factors; therefore, each unit may have to accommodate particular interventions and
surveillance in order to improve patient outcomes. Determining if there was a causal relationship
between device use and risk factors can provide additional information pertaining to incidence of
infections. Addressing the device-related nosocomial infection gaps in the literature could
contribute to creating comprehensive interventions suited for each intensive care unit population.
There have been no recent identified scholars who have taken into account device-related HAIs
by patient outcomes, risk factors, and microorganism epidemiological characteristics such as
Gram-stain; biological classification (genus and species); and antibiotic susceptibility patterns
for each CAUTI, CLABSI, and VAP. In addition, I looked at the association between age,
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gender, and race within the three ICUs to determine if any of these factors played a role in
contributing to device-related nosocomial infections. The data were derived from the patient line
listing that included the microorganisms identified as contributing to the infection.
Purpose of the Study
The purpose of this study was to evaluate epidemiologic characteristics of deviceassociated infections (CLABSI, CAUTI, and VAP) within three ICUs in a large teaching
academic medical center, which consists of two hospitals with an infection control program. This
research aided in the understanding of the types of device associated infections by knowing the
distribution patterns of each ICU and determinants such as persons affected and the correlation
of the location with the ICU type.
In this study, I compared the incidence rates of HAIs in a medical-surgical ICU,
cardiovascular ICU, and a neurosurgical ICU in a large, acute care teaching hospital setting. The
aim of this study was to evaluate characteristics, such as organism types, infection patterns, and
patient demographics, and risk of developing nosocomial infections within three ICUs in a large
medical teaching facility. The goal was to compare and contrast ICU patient outcomes, risk
factors, and the microorganism epidemiological characteristics such as Gram-stain, biological
classification, antibiotic sensitivity, and resistance of each pathogen identified as causing the
HAI within the ICU population. Attention was focused on incidence rates of device-related
nosocomial infections, association between severity of illness and types of device-related
nosocomial infection, demographics and acquiring device-related nosocomial infections, and the
differences between types of microorganisms associated with device-related nosocomial
infections in three adult ICUs. The results from this study could lead to positive social change by
delivering insight that could lead to the development of additional future studies related to
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nosocomial infections. This could then lead to the development of new processes and
interventions to help minimize nosocomial infections with the ultimate goal of improving patient
health outcomes. Ideally, improvements in critically ill patients could be beneficial with regard
to the incidence of HAIs, decreased length of stay, comorbidities, and cost for both the patient
and hospital. The information from this study could aid public health by focusing on ways to
prevent and control the risk of contracting HAIs and lead to development of future studies.
Theoretical Framework
The ecosocial theory of disease distribution was the guiding framework for this research.
Descriptive theory employs an empirical method to describe and classify events by summarizing
the commonalities found in the research observations (Krieger, 2009). This research
encompassed the identified device-related HAIs and investigated factors associated with the
different intensive care units. The ecosocial theory of disease distribution and the ecosocial
model provided the framework used to develop a multilevel approach that could account for the
possible pathways for interaction between determinants, as well as the simultaneous effects of
ecosocial levels on disparities (Krieger, 2014). This approach should also result in new
understanding of how the levels and inequalities in social advantage (i.e., age, race and ethnicity,
and gender) interact to produce disparities. The ecosocial model was used to understand how
biological factors (age, gender, race, and ethnicity), processes (central-line, Foley catheter, and
ventilator usage), and environment (three different ICUs) interact and contribute to HAIs.
Following the guiding principles of the framework allows for the systematic approach to identify
disease patterns and to develop an explanation of the disparities that exist in ICU populations.
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Research Questions and Hypothesis
RQ#1: Is there a difference in the incidence rates of device-related nosocomial infections
between the different types of ICUs?
H01: There is no difference in the incidence rates of device-related nosocomial infections
between the different types of ICUs.
H11: There is a difference in the incidence rates of device-related nosocomial infections
between the different types of ICUs.
RQ#2: What is the association between severity of illness, measured by the Acute
Physiology and Chronic Health Evaluation II (APACHE II) score and CLABSI, CAUTI, and
VAP?
H02: There is no association between severity of illness (APACHE score) and CLABSI,
CAUTI, and VAP.
H12: There is an association between severity of illness (APACHE score) and CLABSI,
CAUTI, and VAP.
RQ#3: What is the association between age, gender, race, and ethnicity from the device
associated HAIs identified in the three different adult ICUs within an academic medical facility?
H03: There is no association between age, gender, race, and ethnicity from the device
associated HAIs identified in the three different adult ICUs within an academic medical facility.
H13: There is an association between age, gender, race and ethnicity from the device
associated HAIs identified in the three different adult ICUs within an academic medical facility.
RQ#4: Are there significant differences in the types of microorganisms (e.g., genus,
species, and susceptibility according to the Clinical and Laboratory Standards Institute (Patel et
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al., 2015) that are associated with device-related HAIs in three adult ICUs within an academic
medical facility?
H04: There are no significant differences in the types of microorganisms (e.g., genus,
species, and susceptibility) according to the Clinical and Laboratory Standards Institute (Patel et
al., 2015) associated with device-related HAIs in three adult ICUs within an academic medical
facility.
H14: There are significant differences in the types of microorganisms (e.g. genus, species,
and susceptibility according to the Clinical and Laboratory Standards Institute (Patel et al., 2015)
that are associated with device-related HAIs in three adult ICUs within an academic medical
facility.
Nature of the Study
The approach was a nonexperimental, observational study that used a quantitative
prospective methodology and incorporated a historical prospective study of secondary data. The
data were collected from Epic, which is an electronic health record software used by the hospital
to gather patient care information. Epic is a secure database that stores patient data including
demographics, clinical synopsis, graphs of vitals, clinical events, risk scoring, and clinical
documentation along with other vital information. This information was used to determine if
there was an infection classified as an HAI. National Healthcare Safety Network (NSHN)
guidelines are used by infection preventionist to determine if infections are device-associated and
healthcare-related. Statistical data were used to compare incidence rates of infection on any
patient with a central line, Foley catheter, and/or ventilator placement in an adult medicalsurgical, neurosurgical, and cardiovascular ICUs. The data of patients with positive cultures were
abstracted from Epic using TheraDoc, a data mining software, as the interface. The data were
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collected according to guidelines established by the CDC’s NHSN, which determines the
presence of a device-associated infection. The denominator was defined as the number of
patients in the ICUs between 2009-2014 with a central line, Foley catheter, and ventilator. The
incidence rates of each device-related HAI (CLABSI, CAUTI, and VAP) were calculated and
compared separately (Table 4 and Appendix D). I assessed recorded information about intensive
care patients without manipulating the study environment and compared three subgroups of
patients from a hospital database (medical-surgical ICU, cardiovascular ICU, and neurosurgical
ICU) from 2009 through 2014. An electronic database called Theradoc was used to provide
information such as the patient line listing, infection type and acquisition, infection
documentation and classification, demographics, and linked microbiology results. The electronic
TheraDoc database provided the specimen source, collected and resulted dates, organism results,
and susceptibilities. The data were abstracted from TheraDoc, which also included the
identification of the type of device-associated HAIs. Although there were three different ICU
population types, the devices used were the same for all three populations. Multiple variables
were studied for each ICU type, including age, gender, ethnicity, comorbidities (diabetes and
obesity), and severity of illness at admission. The nature of the patients (such as differences in
demographics and severity of illness) may confound interpretations of the results. Comparing the
sex of the patient with respect to the HAI type reveals statistically significant differences for
MSICU and when all three ICUs were aggregated (Table 3). Additionally, there were few
demographic groups possessing statistically significant differences in the mean APACHE score
between patients with and without HAI, both groups possessing smoking habits across racial
groups and ethnicities (Table 11). In this study, I evaluated device-related HAIs, risk factors, and
the relationship of microorganisms within three intensive care units. The definitions for the
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device-related HAIs are based upon standardized definitions, and were predetermined by NHSN
(See Appendix B).
This historical prospective study allowed comparison of different variables at the same
time. This was a standardized method to capture the severity of illness upon admission. The data
were analyzed using SPSS version 21.0 and Stata 12, performing statistical analyses such as ttests, chi-squared tests, and ANOVA.
Definitions
The terminology used to describe and define HAIs in this study was well-defined to assist
in the interpretation analysis. Some of the following definitions are standardized by the NHSN, a
division of the CDC that tracks HAIs in the United States, for the classification of deviceassociated and HAIs (CDC, 2015a).
Adult patients: A patient who was admitted into a hospital setting that was 18 years of
age or older.
Bacteremia: Bacteremia is an infection in the bloodstream caused by the presence of
microorganisms. Bacteremia can be transient, continuous, or intermittent (CDC, 2015c).
Comorbidity: Disease(s) that exist(s) in a study participant in addition to the index
condition that is the subject of study (Last, 2001, p. 36).
Confounder: A variable whose presence affects the outcome that is being studied. It is the
unobserved exposure that might have an effect on the outcome of interest and can be correlated
with both the dependent and independent variables (Pourhoseingholi, Baghestani, & Vahedi,
2012). A variable that can cause or prevent the outcome of interest (Last, 2001, p. 38).

12

Device associated infection: An infection in a patient with a device such as a central-line,
Foley catheter, or ventilator that was used for greater than 2 calendar days before the onset of
symptoms (CDC, 2015a).
Device infection rate: The number of device-associated infections (cases) divided by the
total number of device days multiplied by 1,000. Device days are the number of days each device
was used for all the patients during a specified period (central line, Foley catheter, or ventilator;
CDC, 2015a).
Device utilization ratio: The number of device days divided by the number of census
days for a particular unit. It provides a use ratio that can be compared to other units within a
facility and/or with similar unit populations. The ratio can provide information on over usage
(Dudeck et al., 2011).
Disease: A physiological/psychological dysfunction (Last, 2001, p. 52). Physiology
changes related with damages to the body’s organ system.
Healthcare-associated infection (HAI): Can also be referred as a nosocomial infection. A
localized or systemic condition resulting from an adverse reaction to the presence of an
infectious agent and/or the toxins produced by the microorganism causing the infection (see
nosocomial infection definition; CDC, 2016).
Incidence: The number of instances of illness commencing, or of persons falling ill,
during a given period in a specified population, or the number of new events (e.g., new cases of a
disease in a defined population) within a specified period of time (Last, 2001, p. 91). For this
research the study, incidence rate were analyzed quarterly and yearly for a period of 5 years,
from 2010-2014.
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Infection: Invasion of the body tissues of a host by an infectious agent, whether or not it
causes disease (CDC, 2015a). The term infection was used when there was multiplication and
invasion of microorganisms in tissue or any other body surfaces associated with tissue reaction.
Infection involves the growth of microorganisms that result in damage to the host (Horan,
Andrus, & Dudeck, 2008; Tao, Hu, Rosenthal, Gao, & He, 2011). The severity of the infection
and damage depend on many factors. Some of the factors include the organism’s ability to cause
disease, the body site of the infection, and the general health of the individual.
Mean Standardized Infection Ratio (SIR): An average of SIR numbers. For this study, a
calculated central value from yearly SIR averages ranging from 2010-2014. Each years SIR was
added and then divided by how many numbers were averaged (CDC, 2016).
National Healthcare Safety Network (NHSN): CDC’s NHSN is the nation’s tracking
system for HAIs. NHSN provides the nation with the data needed to identify problem areas. The
network helps facilities measure progress of prevention to provide reduction or elimination of
HAIs (CDC, 2016).
Nosocomial Infection: Nosocomial infections, also known as HAIs, are localized or
systemic conditions that result from an adverse reaction to the presence of infectious agents or
toxins (CDC, 2015a). The CDC (2015a) defined these infections as hospital-acquired if they
developed after admission with no evidence that the infection was present or incubating during
admission. HAIs can be caused by endogenous sources such as skin, nose, mouth and
gastrointestinal tract or exogenous sources such as personnel, visitors, medical devices and
healthcare environment (CDC, 2015a).
Present on admission (POA): This term refers to infections that occur during admission
or within the first 2 days after admission into the hospital setting. The infection began prior to
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admission and was not caused during hospitalization. POAs are not reported as HAIs (CDC,
2015a).
Septicemia or sepsis: Septicemia or sepsis is a condition where bacteria and/or their
toxins are in the bloodstream and they are causing infection along with systematic inflammatory
response to an individual. During sepsis the clinical manifestation can reveal fever with
temperature >38o C or hypothermia with temperature < 36o C; chills, white blood cells >12,000,
or hypotension (CDC, 2015c).
Smoking: Tobacco encased in cigarettes, pipes, and cigars that contain nicotine that is
inhaled into the lungs and is dispersed into the rest of the body. I classified smokers as any
person smoking on a daily basis.
Standardized Infection Ratio (SIR): A summary statistic that is used to compare the
actual number of HAIs with the predicted number based on a baseline of the U.S. standard
population. It is used to measure relative difference in HAI occurrence during a period of time
(CDC, 2015a; CDC, 2016).
Urinary tract infections: The urinary tract anatomy includes the kidneys, ureters, bladder,
and urethra, and infections to this area are characterized as either upper or lower infections.
Urinary tract infections are defined as bacteriuria also known as bacteria in the urine.
Quantitative cultures are used to determine if the UTI is diagnostic by determining if the urine
culture was a contaminant, colonization, or infection (CDC, 2015b; CDC, 2016).
Ventilator associated pneumonia: Pneumonia caused in the lower respiratory tract due to
mechanical ventilation. Ventilator-associated pneumonias are defined as a pneumonia that is
caused when a patient was on a mechanical ventilator for greater than 2 calendar days, with day
of ventilator placement being Day 1 (CDC, 2015d; CDC, 2016).
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Assumptions
This study included several assumptions. There are defined policies and procedures to
standardize care to ensure optimal treatment for all patients. Varying immune status, condition of
the patient, and the potential variation of prophylactic antibiotics could result in varying
incidence rates between the three units. Due to patients’ varying conditions upon admission and
given the different types of ICU, the severity of illnesses was quantified using the APACHE
score system, which addresses the degree of acute illness and chronic health status of ICU
patients (Knaus, Draper, Wagner, & Zimmerman, 1985; Vincent & Moreno, 2010). Thus, I
looked to see if there were statistical differences between device-associated infections and
severity of illness of patients in the three ICUs using APACHE scores.
APACHE II scores were used as an additional tool for analysis. The APACHE II scores
were collected by one of the infection preventionists and the informatics analyst. It was assumed
that the collection of the APACHE II scores were reliable because only those two individuals
developed the data and were trained to use the same computerized worksheet format. The
abstraction of the APACHE II score data used standardized definitions, computerized calculation
methods, and strict adherence to the guidelines. It was assumed that the data represented the first
24 hours after the ICU admission. The elements used to calculate the APACHE II scores and
determine the severity of illness can be found in Table 1. The APACHE II score was an
additional analytical tool that provided a snapshot of the patient’s severity of illness. According
to Donahoe (2009), the APACHE II is one of the most widely used methods to describe the
severity of illness in patients. In Donahoe’s study, the APACHE II score was found to provide a
highly reliable severity of illness scoring system especially when the scoring was limited to
individuals who have been trained to collect the data.
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Another assumption in this study was that the care given to the patients was uniform in
quality because patients are critically ill. The experience and education levels of the physicians
and nurses placing and maintaining invasive devices should be similar if comparisons are to be
made between units, as lower experience levels among physicians and nurses placing devices are
associated with increased risk of infection and complication (Cardo et al., 2010; Yokoe et al.,
2008). I expected that hospital staff was following the infection prevention and control policies
and procedures that were in place to prevent infections from occurring. For example,
standardization care can be measured and validated by usage device-associated care bundles.
Care bundles include central line, Foley catheter, and ventilator checklist of best practices as
measured by hospital quality and performance improvement committees. A care bundle is a set
of evidence-based interventions for a defined patient population. However, it was important to
note that even implementing care bundles, which include avoiding femoral sites, strict handhygiene, full barrier precautions, the use of chlorhexidine skin preps, and removal of unnecessary
catheters, it was found that device-associated infections still remain prevalent in U.S. hospitals
(Callister et al., 2015).
The final assumption was that the infection control team, nurses, and physicians in the
hospital were uniformly adept at identifying the various nosocomial infections within each of the
three units. Validation of these nosocomial infection identifications are processed and confirmed
by the infection prevention department by use of the standardized NHSN/CDC definitions for
HAIs. When verifying device-associated HAIs, data such as age, gender, race and ethnicity, and
severity of illness are not used for further comparative analysis within the infection prevention
department. Although the infection prevention department identifies nosocomial infections, the
gap in knowledge was the analysis of the statistical differences (if any) of incidence rates
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between ICU types, microorganism population type, demographics, and risk factors associated
with these types of nosocomial infections.
With respect to the statistical tests used in the analyses, there are a number of
assumptions. For the chi-squared tests, the dataset should be a large, simple random sample and
the patients should not be dependent on each other (i.e., independent observations); which has
been fulfilled, as number of observations in the data set exceeded 4,000 and the individual
answers in the survey from each patient were independent of others. For ANOVA there must
exist constant variance for the groups, the relationships between variables requires linearity.
Because demographic characteristics do not change over time (except age, which increases
linearly) and due to the inherent traits of the APACHE II scores that have been previously
discussed, variance was constant and relationships were linear.
Scope and Delimitations
The aim and scope of this research was to evaluate the causative elements of device
associated infections in the medical surgical, neurosurgical and cardiovascular ICUs. Critically
ill patients in the ICUs are more likely to acquire a device-associated infection (Tao et al., 2011).
Hence, APACHE scores were included for analysis. Thus, the research may assist in the
understanding of the nosocomial infections as well as how to plan and implement preventive
measures in an acute care environment. This research provides information on ways to reduce
HAIs and improve patient safety and outcomes in the acute care setting. Examining confounders
such as gender, age, obesity, diabetes, and smoking could make the study findings more precise
and facilitate a comparative analyses. Additionally, this research may potentially provide a guide
in developing future interventions and incorporate different quality improvement strategies to
reduce device-related nosocomial infections if further prospective studies are established.
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This study was limited to the adult population, both male and female, in the medical
surgical, neurosurgical, and cardiovascular ICUs of an academic medical center, which consisted
of two hospitals, from 2010 to 2014. The neonatal intensive care unit (NICU) was not included
in the study because their criteria to identify HAIs are different from adult ICUs in that birth
weight was used. Furthermore, Foley catheters were not used in the neonatal population in this
acute care teaching facility. Insurance was used as an indicator to determine the socioeconomic
status of the population in the study. Although I focused on device-related HAIs in the ICUs, the
constraints included examining each of the 21 components within three categories (age,
physiological component, and chronic health) that make up the APACHE II score and their
potential role in acquiring device-associated infections. The three categories used in the
APACHE II system included information on age, physiological components, and chronic health,
which were recorded for each ICU in the electronic patient chart in order to determine severity of
illness (APACHE II score). The use of computerized clinical information calculated each of the
APACHE II scores reliably. Other unforeseen factors that may influence the research outcomes
include complications of surgical procedures, adverse reactions, debilitating conditions, and
inadequate documentations related to lines and devices. However, because I aimed to evaluate
factors contributing to nosocomial infections in three ICUs, the results from the findings may
assist in developing new interventions and new processes in patient safety specific to the
teaching facility. However, though the factors such as age, gender, and severity of illness were
the contributing factors being analyzed, these factors could be confounding by indication as most
patients admitted to ICUs tend to be older and already in poor health, thus predisposing them to
other infections. To control for confounding variables, mean APACHE II scores were compared
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between patients with and without HAI for each category of age, gender, and race/ethnicity
under various combinations of risk factors (i.e., obesity, diabetes, and smoking habits).
Limitations
A major limitation of this study was that the majority of the patients in the hospital were
referred from other facilities such as long term acute care (LTAC) and were admitted with
lines/devices in place, thus making these patients predisposed to developing infections. It was
assumed that patients admitted to the ICU had higher risks of developing infections due to their
higher level of acuity upon admission. The majority of these ICU patients were referred from
other facilities for higher level of care than the transferring facility can provide. An additional
limitation was that the study findings were not applicable to every ICU population at a national
level. ICUs in different geographic areas may have diverse environmental, economic, and
population demographics that may predispose patients to an increased or decreased likelihood of
developing a nosocomial infection. However, the population for the acute care facility was not
limited to a geographic area, thus providing a more diverse demographics for the study.
Furthermore, patients residing in non-teaching facilities may be exposed to different levels of
care or available technologies, medications, and equipment. The varying types of ICUs, for
example neurology, cardiology, and medical surgical, may affect the types of infections and
organisms detected.
Limitations may exist due to the three different ICU patient populations, which may
impact the interpretations of these results. Having three different ICUs with varying population
may have had an impact on the analysis and the interpretation of the results. The outcomes of the
study, which include understanding the demographic characteristics ICU patients, may highlight
demographic limitations in future research studies of nosocomial infections. The demographic
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findings may provide additional information about potential commonalities and patterns that may
be involved in device-associated HAIs. Other concerning limitations included confounding
factors such as gender, age, diabetes, obesity, and smoking. To control for these confounding
factors, each subgroup of these factors were held constant when making comparisons across
ICUs.
The final limitation of the study was that the competency of the infection control
personnel and physicians could have affected the data collection methods. The study was
dependent on microbiology testing being ordered and collected when a patient exhibits
symptoms of infection. If testing were not performed, the data would be skewed to show falsely
low rates of HAIs. Additionally, the data were dependent on competent infection control
personnel using subjective and objective criterion to classify infections. Differences in practice
and experience in infection control personnel could render varying data. To ensure data integrity
and accuracy, the data mining software TheraDoc was utilized to validate training and
competency of infection preventionists. Quality assurance was performed using parallel testing
of data from microbiology culture reports and TheraDoc data abstraction. Educational testing
modules were used to confirm and ascertain the appropriate training of infection prevention
personnel. Ignoring a multilevel approach and focusing on a single determinant produces an
incomplete understanding of how to reduce HAIs and was likely to limit the effect of an
intervention. Although an attempt to control the confounding factors was made, a limitation of
this approach would be that the lifestyles of the patients, such as specific dieting habits, were not
recorded in the clinical data. The potential impact on the results may cause differences in the
statistical significance in the chi-squared tests and thus possible estimation bias in the p-values.
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Therefore, future research could include interventions that can systematically address the issue of
HAIs in the intensive care unit at each ecosocial level.
Significance
The results to this study may lead to enhanced understanding of the elements involved
in the transmission of infection. The purpose and significance of the study may also demonstrate
outcomes and relationships that can possibly be helpful in understanding the relationships of the
host, environment, and organisms involved in each device-associated HAI. It was important to
understand the association between risk factors and infection in the different ICU settings in
order to determine how these findings can be used to reduce infection risks for the three different
ICU patient populations. Each of the patients were all 18 years of age or older, and each patient
was admitted into one of the three ICUs during 2010-2014. Although there were three distinct
ICU populations, they all were considered to be critically ill patients. However, the differences in
population included neurosurgical ICU patients who are cared for and monitored for intracranial
and hemodynamic monitoring such as brain injury or stroke, tracheostomy and nutritional
support and who receive less sedation than other ICUs (Kurtz et al., 2011). As for cardiovascular
ICU patients, that population is mainly treated for heart failure, and any other cardiovascular
problems such as heart attacks, cardiac surgery, and cardiothoracic pathophysiology. In the
medical-surgical ICU population, the focus is on patients who have acute exacerbation of chronic
health problems (COPD, CHF, ESRD, etc.) with acute illness or any failure of major systems in
the body following surgery or patients who have experienced trauma injuries and any immediate
risk of complications. Despite these differences in ICU types, all three intensive care units
require higher acuity and complexity of care.
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The HAIs, specifically central line-associated bloodstream infections (CLABSI),
represent a significant safety risk to critically ill patients. According to (Perencevich & Pittet,
2012), HAIs have a vast economic cost of $6.5 billion in excess expenditure annually and an
estimated 100,000 deaths in the United States. Central-line bloodstream infections are one of the
leading causes of HAIs (Perencevich & Pittet, 2012). According to scholars, 65% to 70% of
CLABSI and CAUTI cases are preventable, and 55% of VAPs are also preventable if evidencebased practices and strategies were used (Umscheid et al., 2011). The HAIs are a primary cause
of morbidity and mortality with an estimated 1.7 million HAI cases reported in the United States
(Septimus et al., 2014). It was estimated that 20%-70% of HAIs are thought to be preventable
(Nakamura, Fukushima, Hayakawa, Sekiya, & Matsumoto, 2015).
Summary
Patients in the intensive care units often require life-saving therapies that involve the use
of invasive medical devices. Unfortunately, these invasive devices also carry the threat of
nosocomial infection, which can increase patient morbidity, mortality, length of stay, and cost of
care. According to O’Grady et al. (2011), it was estimated that in the United States alone, there
were 15 million central vascular catheter days that occur in the intensive care units each year. It
was estimated that 80,000 central line bloodstream infections occur in the ICUs each year
(O’Grady et al., 2011). The total cost of nosocomial infections account for nearly a third for ICU
in-patients (O’Grady et al., 2011). Given the severity of the threat device-associated HAIs pose
to patients in intensive care units, it was necessary to examine the risk factors, comorbidities, and
microbiology of different intensive care units, as well as the differences between them. In this
historical prospective study, I examined these factors to identify any significant associations with
device-associated HAI rates. The results of this study could result in novel approaches to address
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device-associated nosocomial infections. The findings could help to focus on implementing
prevention approaches and guidelines depending on the ICU patient population. The awareness
and better understanding of healthcare associated infections (HAIs) related to devices is
problematic and the healthcare industry should continue to promote quality improvements and
prevention of HAIs. The following literature review on hospital-acquired infections builds the
foundation for the research study to evaluate factors contributing to device-related infections in
acute-care setting.
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Chapter 2: Literature Review
Introduction
Device-associated HAIs are increasingly being recognized in the scientific literature as
the preeminent threat to patient safety in the ICU, contributing to patient morbidity, mortality,
and economic cost of care (Guanche-Garcell et al., 2011). The use of multiple therapies, invasive
procedures, and devices including mechanical ventilators and central venous, pulmonary artery,
and urinary catheters leaves the critically ill patient population at an increased risk of developing
device-related healthcare associated infections DA-HAIs (Tao et al., 2011). Scholars have
estimated that the number of HAIs in the United States was approximately 1.7 million with
99,000 annual deaths. It was estimated that the cost of HAIs each year was over $10 billion
dollars (Septimus et al., 2014). It was also estimated that 48% of patients in the ICU have a
central line catheter in place (Sacks et al., 2014). According to Sacks (2014), there are 80,000
catheter-associated bloodstream infections each year, which accounts for 24,000 deaths reported
from CDC.
Literature Search Strategy
The majority of the published studies that were summarized and used for this
investigation included scientific journals, government agency websites, and websites of
professional organizations. A systematic literature search for comparative historical studies was
performed on PubMed, MEDLINE, JAMA, and IDSA. Some scientific journals were searched
by using Google search engine and PubMed library, limiting the time range from 1990 to 2014.
The search was conducted by using keywords such as social epidemiology, ecosocial theory,
microbiological pathogens, infection control, and infectious diseases. The use of relevant articles
included peer-reviewed journals obtained from the Walden University Library and the UT
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Southwestern Health Sciences Digital Library and Learning Center. The peer-reviewed journals
used included Morbidity and Mortality Weekly Report (MMWR), The New England Journal of
Medicine, Critical Care Medicine, Infection Control & Hospital Epidemiology, Public Medicine
Journal, Clinical Infectious Diseases, International Journal of Infectious Diseases, and
American Journal of Infection Control (AJIC) from 2005-2016.
Theoretical Framework
The ecosocial theory of disease distribution provided the theoretical framework to
understand what and how determinants of health, both biological and social, interact and
contribute to HAIs. Following the guiding principles of the framework allows for the systematic
approach to identify disease patterns and to develop an explanation of the disparities that exist in
ICU populations. This theory was developed by Krieger in 1994 to incorporate social and
biological conditions in shaping the population’s health overtime (Krieger, 2001). Different from
other social epidemiology theories, that focus on aspects of social and biological conditions in
shaping the population’s health, the ecosocial theory of disease distribution (Krieger, 1994) is
used to explain patterns of health in relation to different levels of biological, ecological, and
social organization—from cell organization to society to the ecosystem (Krieger, 2001, 2014).
Recognizing how social and biological factors contribute to the epidemiology of diseases,
the central question for ecosocial theory is “who and what is responsible for population patterns
of health, disease, and wellbeing, as manifested in present, past, and changing social inequalities
in health?” (Krieger, 2001, p. 668). The ecosocial constructs include embodiment; pathways of
embodiment; cumulative interplay between exposure, susceptibility, and resistance; and
accountability and agency. Embodiment refers to the relationship between the social and
biological world and an individual’s body (Krieger, 2001, 2014). Pathways to embodiment

26

describe the processes in which social, biological, and environmental factors interact with a
person’s body, including evolutionary history, ecological context, and individual histories (both
biological and social development).
This, this theory includes spatial-time component. The cumulative interplay of exposure,
susceptibility, and resistance explains how disease patterns are affected by people’s biological
and social histories and experiences at multiple levels over the life course. In accountability and
agency, institutions (individual and households, government, business, and public sector) are
responsible for monitoring, analyzing, and addressing patterns of diseases (Krieger, 2001, 2009,
2014). These ecosocial constructs may guide in the understanding of disease patterns and
determinants of health of ICU populations, in relation to device-related infections. The ecosocial
approach factors such as social determinants of health and biological determinants of health that
led these populations to the ICU was analyzed. For this research, the ecosocial theory (Krieger,
2009) was adapted for this research as a conceptual framework to determine factors that
influence the incidence rates of device-associated infections in an acute care setting. Figure 1
illustrates the ecosocial conceptual model that includes the pathways to embodiment adapted
from Krieger (2001).

27

Agency/Accountability

Embodiment

Biological/Social

Behavioral

Age
Gender
Race/Ethnicity
Socioeconomic Status
Illness/ Comorbidities

Smoking
Physical Activity
Nutrition

Environment

Process

Length of stay
Exposure to
microorganisms
ICUs (Neuro-Surgical,
Cardiovascular, MedicalSurgical)
Multi-drug Resistant
Organisms (MDRO)

Medications
Medical Procedures
Medical Devices

Pathways to embodiment

Figure 1. Ecosocial conceptual model.
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Types of Device-Related Healthcare Associated Infections
Catheter-Associated Urinary Tract Infections
The introduction of medical devices, such as Foley catheters, into the urinary tract that
remain in place for extended periods of time carries a risk of infection. Device associated urinary
tract infections are tied with pneumonia as the second most common type of nosocomial
infection (Horan et al., 2008). These types of device-associated infections account for more than
15% of infections in acute care facilities and are associated with more than 13,000 deaths each
year (Horan et al., 2008). These infections can lead to further complications such as cystitis,
pyelonephritis, prostatitis, bacteremia, epididymitis, and other complications (Horan et al.,
2008). The CAUTIs are a complication of diabetes, renal disease, and structural abnormalities
that interfere with urine flow. It was estimated that CAUTIs are the origin for about half of all
nosocomial infections (Clarke et al., 2013). The CAUTIs are one of the most common HAIs in
the United States and are preventable as well (Kennedy, Greene, & Saint, 2013).
The CDC (2015b) defined urinary tract infections as symptomatic urinary tract infections
(SUTI) or asymptomatic bacteremic urinary tract infections (ABUTI) based on differentiating
criteria (Horan et al., 2008). SUTIs are divided into four different classifications (SUTI 1-4)
based on age and the number of colony forming units (CFU)/ml present in the urine culture
(CDC 2015b). These four classifications are further divided into subtype A and B based on
whether the infection was catheter-associated. Subtype A requires that an indwelling catheter
was in place >2 calendar days and was removed the day of or the day before the infection,
whereas subtype B requires that an indwelling catheter was not in place or was in place for <2
calendar days (CDC 2015b). SUTI 1 and 2 include any age, while SUTI 3 and 4 are limited to
infants (CDC 2015b). Because the ICUs included in this study were exclusively from an adult
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population, I only examined SUTI 1a, 2a, and ABUTI device associated infections. See
Appendix A and B for CDC/NHSN criteria.
Central-line Bloodstream Infections
The CDC’s National Healthcare Safety Network (NHSN) defines a central line as “an
intravascular catheter that terminates at or close to the heart or in one of the great vessels that is
used for infusion, withdrawal of blood, or hemodynamic monitoring" (CDC, 2015c p.2). Central
venous catheters (CVC) are used on patients for multiple purposes to provide parenteral
nutrition, drug and other fluid administration. It is estimated that more than 5 million central
venous catheters are placed each year increasing the incidence of adverse events (McGee &
Gould, 2003). One of the major problems associated with these devices is the risk of nosocomial
infections (HAIs). According to literature review, these device-related infections are harmful to
patients, typically increasing length of stay, cost of care, and risk of mortality (Perencevich &
Pittet, 2012). NHSN defines a central line-associated bloodstream infection as a primary
bloodstream infection in a patient who had a central line within the 48-hour period before the
development of the bloodstream infection (Horan et al., 2008). These infections are of particular
concern in intensive care units where, at any given time in the US, half of all patients have an
indwelling CVC (Sacks, et al., 2014). Central-line bloodstream infections are a leading cause of
HAIs with approximately 80,000 intensive care unit cases occurring annually and around 24,000
patient deaths (Perencevich & Pittet, 2012). In all, hospital associated infections are a common
and potentially harmful patient safety issue in the U.S. and world-wide (Krein, Kowalski, Hofer,
& Saint, 2012). Several mechanisms have been proposed for the occurrence of catheter-related
infections: infection of the exit site followed by migration of the pathogen down the external
surface of the catheter; contamination of the catheter hub, resulting in intraluminal catheter
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colonization; and hematogenous seeding of the catheter (O’Grady et al., 2011). See Appendix B
for CDC/NHSN criteria.
Ventilator Associated Pneumonia
Mechanical ventilators ease the work of breathing in those patients who are unable to
breathe on their own, usually by connecting the patient to the ventilator via endotracheal
intubation or tracheostomy. In addition to the life-saving benefits mechanical ventilation offers
to those patients suffering from critical illness and respiratory failure, mechanical ventilation is
also associated with significant risk for complications and poor outcomes. Negative outcomes
associated with mechanical ventilation include death, ventilator-associated pneumonia (VAP),
sepsis, acute respiratory distress syndrome (ARDS), pulmonary embolism, barotrauma, and
pulmonary edema (Kalanuria, Zai & Mirski, 2014). These complications often result in increases
in the duration of ventilation, length of stay in the ICU and hospital, cost of care, risk of
disability, and risk of mortality.
It is estimated that more than 300,000 patients receive mechanical ventilation each year
in the United States (Peyrani, 2009). Further, Magill et al. (2014), estimated that in 2011 there
were 157,000 healthcare associated pneumonias identified in U.S. hospitals. Half of all VAP
cases are responsible for hospital acquired pneumonia and it is estimated that 9-27% of all
mechanically ventilated patients acquire a VAP during the patient’s early course of
hospitalization (Kalanuria et al., 2014). The National Healthcare Safety Network (NHSN)
reported more than 3,957 ventilator associated pneumonias with an incidence range from 0.0-4.4
per 1,000 ventilator days for the year 2012 (CDC, 2015d). Pneumonia clinically causes
inflammation of the lower respiratory tract which involves the lungs airways and supporting
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structures. Pneumonia is a major cause of illness and death in hospital settings (Pogorzelska et
al., 2011).
To be considered a VAP, the patient must be intubated and ventilated at the time of, or
within 48 hours of the onset of the event (Peyrani, 2009). It was important to mention that the
duration of ventilation was not relevant for identifying a VAP, i.e. there was no minimum time
the ventilator must be in place to be considered a VAP. The diagnostic criteria for VAP for this
research study was based on the old protocol prior to the ventilator associated events set forth by
the CDC (Dudeck et al., 2013). The criteria used for identification separates pneumonia into
three different classifications, PNU1, PNU2, and PNU3, based on differences in patient signs,
symptoms, and laboratory results (Horan et al., 2008). It was important to note that a pneumonia
diagnosis alone was not an acceptable criterion for VAP. Further, determining the presence of
pneumonia can be complicated by other health conditions, including respiratory distress
syndrome, pulmonary embolism, and other respiratory diseases (Kalanuria et al., 2014). Early
onset pneumonia can also be mistaken for tracheal colonization or upper respiratory tract
infections. Consequently, it was important that the specific site algorithms established by the
CDC are followed in order to ensure accurate diagnosis, treatment, and reporting (Peyrani,
2009). All three classifications of pneumonia require the same radiology testing and results,
requiring more than two chest x-rays that have cavitation, consolidation, and persistent infiltrates
which may be new or progressive (Peyrani, 2009). See Appendix B for CDC/NHSN criteria.
Surveillance and Prevention Guidelines
In the United States, the CDC reports that surveillance plays a leading role in reducing
DA-HAIs (Doshi, Patel, MacKay, & Wallach, 2009). Further, the Study of the Efficacy of
Nosocomial Infection Control (SENIC) has suggested that approximately one third (32%) of
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HAIs are preventable through programs of surveillance and infection control (Sydnor & Perl,
2011). Active infection control surveillance and the implementation of evidence based guidelines
and practices can increase patient safety and reduce the incidence of HAIs. Reported findings
showed a decrease in incidence of HAIs in ICU settings by incorporating an educational program
focused on interventions directed at ICU clinical staff (Sacks et. al., 2014). Surveillance was
crucial in recognizing outbreaks, trends, HAIs, and emerging infectious diseases in order to
implement control measures to aid in controlling the spread of infections (Rosenthal et al., 2012).
Incidence and Complications
The use of Foley catheters in an intensive care unit are used routinely to monitor urine
output, for convenience and necessity. Urinary tract infections are problematic particularly with
patients in the intensive care units. These urinary tract infections account for 32% of health care
associated infections (Elpern et al., 2009). According to Nicolle (2014), CAUTIs are one of the
most common HAIs especially with patients who have indwelling urinary catheters in place.
Complications include lower abdominal pain, burning urination, and frequency to urinate.
Urinary tract infections are known to be associated with secondary bloodstream infections given
the high frequency of indwelling catheter use especially in the critically ill patients (Nicolle,
2014). The CDC (2015b) states that urinary tract infections are the third most common
healthcare associated infection which account for more than 93,000 infections in hospitals alone.
The use of antibiotics can predispose an individual for acquiring other multidrug resistant
organisms which in turn can increase the risk for potentially more severe conditions.
Central vascular catheters are used as a resource to provide nutrients, medicine, fluids
and even take blood samples without having to use a needle to stick a patient. There can be
serious complications with any central line bloodstream infection (Marschall et al., 2014). The
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complications include prolonged length of stay, mortality and the increased cost of medical
services. The clinical manifestations of a central line bloodstream infection can include fever,
chills, and/or hypotension (Pronovost et al., 2006). Once the microorganisms are in the
bloodstream they can be carried to other parts of the body and in turn can cause organ damage.
Other complications include urosepsis which can progress to septic shock. Septic shock is a
serious and life threatening complication which can lead to a drop in heart rate and blood
pressure along with decrease in urine output and an altered mental status.
Risk Factors
The most prominent risk factor for developing a CAUTI was extended use of a urinary
catheter (Clarke et al., 2013). However, other prominent risk factors include a disconnection of
the catheter drainage system and a lower level of professional training and experience of the
inserter (Clarke et al., 2013). Female sex, old age, impaired immunity, having a catheter placed
outside of an operating room, incontinence, diabetes, meatal colonization, and renal dysfunction
are also associated with an increased risk of developing a CAUTI or catheter-associated
bacteriuria (Edwards, Peterson, & Andrus, 2007; Gould et al., 2009).
Nosocomial infections in ICU patients are especially at risk for adverse consequences due
to their risk factors. Gastmeier, Sohr, Geffers, Behnke, & Rüden, (2007) performed research in a
German-based hospital to determine risk factors for death among patients who acquired
nosocomial infections. The researchers used surveillance data consistent with methods
standardized by the CDC. Based on two primary nosocomial infections in their ICUs, pneumonia
and primary BSI, the researchers investigated risk factors that contributed to death. Though they
found that the types of ICUs and age to be important factors, causative pathogens particularly
antimicrobial-resistance pathogens may influence the outcome of patients with nosocomial
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infections. A limitation of the study, however, was their inability to adjust for severity of illness
at hospital admission. Thus, further investigations of the role of the pathogens in different types
of ICUs that contribute to nosocomial infections are warranted.
The importance of investigating antimicrobial resistance organisms in critically ill
patients who acquired nosocomial infections were further demonstrated by Chen and colleagues
(2012). In this study, prospective surveillance was conducted to determine device-associated
infection rates and incidence of antimicrobial resistance in adult medical-surgical ICU in Taiwan
from 2003-2005, though the surveillance was conducted according to the CDC procedures (Chen
et al., 2012). The findings revealed that through their infection control practices and surveillance
program, the rates of device-associated infections and three of the most common antimicrobial
resistance pathogens causing VAP were decreased (Chen et al., 2012).
Microbial Transmission
Microorganisms in the bloodstream can be continuous, intermittent or transient
depending on the circumstances. Transient bacteremia is incidental and is likely to occur when
brushing teeth, post dental procedures, manipulation of infected tissue, certain surgeries, or
instrumentation of contaminated mucosal surfaces to name a few. Intermittent bacteremia is
usually organisms that make their way into the bloodstream because of other factors such as
abscesses, wounds and other trauma conditions. Continuous bacteremia involves constant release
of organisms into the bloodstream and usually causes septic shock, bacterial endocarditis and
other vascular infections. Microorganisms in the bloodstream can be a threat to any organ in the
human body and can have serious consequences. Some of the serious consequences include
shock, multiple organ failure, disseminated intravascular coagulation and death (Seifert, 2009).
Septicemia or sepsis occurs when the organisms in the bloodstream produce toxins which harm
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the patient. Sepsis is recognized by a sudden increase in pulse rate, temperature and the onset of
chills (Shah, Bosch, Thompson, & Hellinger, 2013). The pathogens can be bacteria, fungi,
viruses or parasites. The organisms that are most commonly linked with bloodstream HAIs are
gram-positive cocci such as coagulase negative staphylococcus, Staphylococcus aureus and
Enterococcus species followed by aerobic gram-negative bacilli and then yeast. A large number
of the gram negative bacilli causing bloodstream infections can be due to gram negative bacteria
such as Pseudomonas aeruginosa. Studies conducted by Durojaiye Carbarns, Murray &
Majumdar, (2011) have reported that Pseudomonas aeruginosa is a major opportunistic pathogen
that is involved in many hospital infections. The study reported that Pseudomonas aeruginosa
has been the cause of outbreaks in intensive care units. The organism’s ability to survive in a
wide range of physical conditions makes it more likely to cause infections especially since
Pseudomonas aeruginosa is essentially resistant to several antibiotics (Durojaiye et al., 2011).
Bloodstream infections can also be caused by organisms that colonize the skin, oropharyngeal
and gastrointestinal tract of patients. Seifert (2009) noted a landmark study by Weinstein and
colleagues (1997) which defined the portal of entry for primary bloodstream infections as
intravascular catheter (19.1%), and secondary sources were genitourinary tract, respiratory tract,
the abdomen, and the skin and skin structure (Seifert, 2009; Weinstein et al., 1997).
The urinary tract consists of the kidneys, ureters, bladder and urethra. Typically when an
infection takes place it is either an upper or lower infection depending on the anatomic location
of the infection. The lower urinary tract consists of the bladder and urethra while the upper
urinary tract encompasses the ureters and kidneys. It was important to remember that the female
gender have a relatively short urethra compared to males thus putting the female gender at a
higher chance of acquiring a urinary tract infection. The reason females have a higher chance of
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infection was because bacteria can reach the bladder in a quicker and easier manner. The urethra
has resident flora that colonizes along the epithelium in the distal portion. The potential
pathogens include gram negative bacilli such as the Enterobacteriaceae. Other pathogens include
yeast and some gram positive cocci. The most common urinary tract pathogen was Escherichia
coli but other frequent urinary tract infections can include bacteria such as Klebsiella species,
and other Enterobacteriaceae (Pallet & Hand, 2010). For gram positive pathogens,
Staphylococcus saprophyticus is a common pathogen in females that are sexually active.
Recurrent urinary tract infections have a tendency to be caused by Proteus, Pseudomonas,
Klebsiella, and Enterobacter (Pallet & Hand, 2010). The hospital environment plays an
important role in determining the microorganisms involved in these types of infections. The
hospitalized patients are inclined to develop a urinary tract infection with Escherichia coli,
Klebsiella species, Proteus mirabilis, other Enterobacteriaceae, Pseudomonas aeruginosa,
Staphylococcus and Enterococcus species (Pallet & Hand, 2010). The introduction of a foreign
body such as a Foley catheter carries a substantial risk of infection (Clarke et al., 2013). In many
hospitalized patients, urinary tract infections are introduced during urinary catheterization or
other manipulations of the urinary tract. Urine is typically sterile and all areas of the urinary tract
above the urethra are sterile in healthy individuals (Clarke et al., 2013).
The respiratory tract is divided into two separate section areas; one section consists of the
upper area while the other section makes up the lower respiratory tract. Infections that are
associated with mechanical ventilation are associated with organisms which can influence certain
traits or certain products to promote colonization and subsequent infection in the host. Most of
the organisms associated with respiratory infections have a propensity to gain foothold within the
respiratory tract to grow to adequate numbers and produce symptoms. Most etiologic agents of
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the respiratory tract disease adhere to the mucosa area of the respiratory tract. The bacteria that
possess specific adherence factors include Streptococcus pneumoniae, and other Strep species,
Staphylococcus aureus, Haemophilus influenza, and many gram negative bacilli. These types of
pathogens cause disease by merely growing in host tissue which in turn causes interference with
normal tissue function. Diseases of the lower respiratory tract include both bronchitis and
pneumonia. There are four major routes of infection with regard to pneumonia causing
organisms. There is upper airway colonization, aspiration of organisms, by inhalation of airborne
droplets or by seeding of the lung via the bloodstream. Hospital acquired pneumonia can be
related to contaminated inhalation therapy equipment. Any intubated patient has an increased
risk of acquiring respiratory nosocomial pneumonia especially when reintubation occurs. The
organisms associated with these types of infections can be hospital specific. However the most
common pathogens related to lower respiratory infections are Pseudomonas aeruginosa,
Klebsiella species, other Enterobacteriaceae, Staphylococcus aureus, Streptococcus pneumonia
and a variety of other common organisms (Kalanuria et al., 2014). Aspiration pneumonia with
infection caused by gram negative bacilli or Staphylococcus is a major type of hospital acquired
pneumonia followed by pneumococcal disease.
Research Studies of Nosocomial Infections in the Intensive Care Units
HAIs are a major cause for concern as it relates to morbidity and mortality, patient safety,
and cost of care (Leblebicioglu et al., 2007; Scott, 2009; O’Grady et al., 2011). There have been
research studies done to demonstrate the efficacy of surveillance to prevent nosocomial
infections. A study related to device associated healthcare infections which was conducted to
determine the epidemiological characteristics of nosocomial infections in combined medicalsurgical (MS) and trauma ICUs within the International Nosocomial Infection Control

38

Consortium (Guanche-Garcell et al., 2011). It was found that BSI, UTI, and respiratory tract
infections were almost always associated with an invasive device, and device-associated
infections in major teaching hospitals were higher than other hospitals with combined medicalsurgical units. This study, however, only looked at two medical-surgical ICU populations from
2006 – 2009. An updated epidemiological study of nosocomial infections is warranted and this
proposed research addresses that gap in knowledge.
In Turkey a prospective study of HAI surveillance was performed in 13 ICUs from 12
hospitals, which were all members of the International Nosocomial Infection Control Consortium
(INICC) (Leblebicioglu et al., 2007). The objective of the study was to determine the incidence
of device-associated infections in the ICUs of the Turkish hospitals to compare them with
international infection control standards, and to plan infection control activities based on the
data. The study looked at CAUTI rates, VAP, and central venous catheter-related BSI. It was
found that device utilization in the ICUs used in the study was similar to that reported in the U.S.
rates of device-association infections in the Turkish ICUs were higher than the CDC National
Nosocomial Infections Surveillance System. The findings of the study were used to inform the
researchers about hospital practices that contribute to nosocomial infections. According to their
study, one of the limitations of this research study was not taking into account patients’ severity
of illness, which might skew the results of the study (Leblebicioglu et al., 2007).
Another study of device-associated nosocomial infections of critically ill patients was
conducted in nine Colombian hospitals (Moreno et al., 2006). The study was conducted in
respond to other published studies of nosocomial infections in the ICUs in developed countries
using CDC standardized definitions. However, few surveillance studies have been performed in
developing countries using standardized definitions (Moreno et al., 2006). The objective the
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study was to perform a prospective study to measure the rate of device-associated infections,
organisms causing the infections, the difference in mortality rates between patients with and
without a device in adult ICU settings (Moreno et al., 2006). It was found that the deviceassociated infections were lower than other published studies in Latin America, but still higher
than those reported in the US (Moreno et al., 2006). The study limitations included the use of
data from only one population -type of ICU (medical-surgical) and the use of a less
sophisticated severity of illness scoring system (Moreno et al., 2006).
Cost of HAIs
Many studies have been conducted to measure the cost of healthcare associated infections
and each type of HAI has its own cost. A study on cost was conducted by Scott (2009), using
results from medical and economic literature to provide a range of estimates for treating
healthcare associated infections. Adjustments were made in the cost with regard to the use of
infection prevention and control interventions. The cost for central line-associated bloodstream
infections are estimated to range from $5,734 to $36,441. The cost for CLABSIs can be
substantial with the possibility of morbidity and financial resources expended (O’Grady et al.,
2011). The estimated cost for ventilator associated pneumonia infections ranged from $11,897 to
$25,072. The estimated cost for catheter associated urinary tract infections ranges from &758 to
$1,006. It was important to keep in mind that each HAI increases the length of stay and increases
the possibilities of prolonged care and can contribute to negative outcomes.
Control and Prevention
Understanding certain factors related to device-related HAIs can provide guidelines and
important solutions in the ICU. The Infection Prevention & Control Program includes
surveillance, data abstraction and preventive measures. However, though surveillance is an
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important aspect of Infection Prevention & Control programs, it can be labor intensive and time
consuming; thus, limiting resources for quality improvement (Reilly, McCoubrey, Cole, Khan, &
Cook, 2015). It is important to focus on prevention from the start rather than treatment after the
fact. The novel approach to this research study was comparing three different ICUs within an
academic medical center. Control and prevention should use measures for early detection and
prompt intervention to control a healthcare problem and minimize the consequences related to
device associated infections. Since policies and guidelines evolve constantly, the findings from
this study may possibly aid in the development of a more comprehensive plan to prevent
nosocomial infections within this facility. However, assessing interventions was not focus of this
study. The use of comparison data with regard to disparities can possibly aid in the development
of policies and procedures to reduce the possibility of device-associated infections and better
treatment strategies in the future. The ability to recognize the differences between risk factors
can contribute to prevention or reduction of HAIs.
The Healthcare Infection Control Practices Advisory Committee (HICPAC) has
established prevention strategies and guidelines to reduce the incidence of CAUTIs. The core
prevention strategies established by HICPAC are evidence based and have demonstrated
feasibility. These strategies include the following: 1) insert catheters only when appropriate,
minimizing use in all patients; 2) remove catheters as soon as they become unnecessary; 3)
ensure that only trained and experienced persons insert and maintain catheters; 4) insert catheters
using aseptic technique and sterile equipment, including performing hand hygiene pre and post
insertion as well as wearing proper PPE; 5) maintain a closed drainage system; 6) maintain
unobstructed urine flow, keeping the collecting bag below the level of the bladder at all times; 7)
use hand hygiene and standard or isolation precautions; 8) implement quality improvement
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programs to reduce the risk of CAUTI by decreasing inappropriate use of indwelling catheters
(Gould et al., 2009).
Summary
Device associated healthcare related infections are associated with an increased length of
hospital stay, an increased chance of additional complications and excessive healthcare costs.
These infections impose significant economic consequences to the healthcare system. All
intensive care unit patients are at increased risk of acquiring HAIs because of the many preexisting comorbidities which may be present in ICU patients. Risk factors play a role in reducing
the body’s resistance to infections however it may be difficult to determine how each of these
risk factors would contribute to HAIs. Physical environmental factors play a role in contributing
to the development of HAIs. The goal must be to prevent these infections rather than identify and
treat these infections. Promotion of best practices must be initiated to include maximal barrier
protection, use of chlorhexidine for skin prior to insertion, avoiding femoral sites for central line
placement, removal of devices when no longer needed. Educational modules should be used
pertaining to the prevention of CLABSI, CAUTI, and VAP. A combination of heightened
awareness with increased accountability, empowerment of frontline staff, and the opportunity for
feedback provides important downward pressure on device associated healthcare infections. The
ultimate goal of this research was to identify the types of device associated infections within
each ICU, the significant risk factors associated with these infections and the microorganisms
linked to these types of infections surrounding the healthcare setting. This research may provide
information which may help guide strategic procedures and consideration of narrowing the
spectrum of antibiotic usage, shortening the utilization of devices such as Foley catheters and
central lines in order to prevent complications and reduce the risk of death. The research could
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provide a positive social change which could benefit the hospitals by conveying an
understanding on the types of problems related to infections due to vascular lines, Foley
catheters and ventilators. Information regarding types of lines, microorganisms, and/or the
environment plays a role in eliminating healthcare associated infection. In conclusion,
determining the underlying relationships related to the microbial growth associated with these
types of infections could help prevent unnecessary prolonged hospital stay, complications, and/or
death.
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Chapter 3: Methodology
Introduction
Nosocomial infections are a cause of concern and have been shown to increase morbidity,
mortality, length of stay, and cost of care in hospitals (Marschall et al., 2014). Critically ill
patients in ICUs are more at risk of acquiring infections due to the invasive nature of treatments
and multiple therapies used, such as mechanical ventilation, central venous, pulmonary artery,
and urinary catheterization (DePalo et al., 2010). Patients with multiple risk factors have higher
incidence rates of developing CLABSI, CAUTI, and VAP (Barnett et al., 2010).
Despite multiple interventions and increased attention directed towards identification and
prevention of CLABSIs, CAUTI, and VAPs, there continues to be ongoing occurrences of these
healthcare device-related infections that patients succumb to during their hospitalization. After
reviewing the literature, a gap in clinical practices was identified between interventions and
attention focused on minimizing these infections, and actual success at completely eliminating
those types of infections (Cardo et al., 2010). Although the focus of this research was not on
assessing clinical practices, the findings of this study may provide suggestions for future
researchers to develop interventions to minimize infections. Specifically, the research aimed to
address the gap in knowledge in regards to the statistical difference analyses (if any) of incidence
between ICU types and risk factors that include severity of illness. Additionally, I included types
of microorganisms identified in each type of device-associated infection. I addressed the
knowledge gap in the associations between the ICUs, device-associated infections, and
microorganisms. The purpose of this historical prospective study was to analyze and compare the
key pathogens, risk factors of ICU patients, and trends of nosocomial infection rates in three
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ICUs (medical-surgical, cardiovascular, and neurosurgical) of a large acute care teaching
hospital setting.
Research Design and Rationale
Reason for Selection of Design
This was a historical prospective study in which data were analyzed from a 5-year
period, enabling examination of the relationship between characteristics of nosocomial infections
in three different ICUs. Quantitative data are more efficient and provide the researcher a greater
ability to test the hypotheses. The study was less time consuming because analysis was from
secondary data using statistical software. Additionally, quantitative evaluation was selected
because the data for this research study included actual numbers, frequencies, and counts of
cases that may help identify data patterns. The goal for the quantitative research was to classify
features and be able to count them and then be able to construct statistical models so that the
research could be explained by what was observed. The clinical component provided quantitative
health status measures of device-associated infections that can impact knowledge, policy
changes, clinical technique changes, and behavioral changes regarding quality healthcare.
Strengths and Key Points of the Research Design
Key points with regard to the strengths of a quantitative research design include
statistical representation, estimation of magnitude and distribution impacts, clear documentation
methods, addressing confounding factors by holding constant certain demographic traits and risk
factors (i.e., diabetes, obesity, and smoking habits), and a standardized approach. Control of
biases, including selection bias, was completed by selecting all ICU patients with deviceassociated HAIs while determining the dissimilarities and similarities of patients by comparing
differences in mean APACHE II scores and chi-squared tests for each subgroup of demographic
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traits and risk factors. In this study I addressed confounding factors, such as controlling for age
and gender, when comparing the mean APACHE II scores for each HAI type and non-DAIs
(Tables 10-19). I took into account patients’ illness severity scores using the APACHE II score. I
did not aggregate the three ICU patient populations in order to prevent masking of aggregated
data that can provide better insights to the data. Confidentiality of the patients was maintained by
randomly assigned numbers.
Methodology
Study Variables and Measures
Dependent variables included numbers of nosocomial device-related infections
(CLABSI, CAUTI, and VAP), the three ICUs, and incidence rates of device-related nosocomial
infections (Table 1). Independent variables included demographics that were age, gender, and
race; risk factors such as diabetes, obesity, and smoking; types of microorganisms; and severity
of illness (APACHE II Score). The data were collected by identifying the number of devicerelated infections and device days from 2010 – 2014. Data from positive lab results from the
electronic health record, for patients with device-related infections, were used in a systematic,
empirical investigation to determine the number of cases and incidence rates of infections. The
denominator was a count of the number of patients with a device, such as central line, Foley
catheter, and ventilator, in each of the ICUs for each month. Microorganisms were investigated
to determine if there were any trend clusters with regard to these types of factors. Trend clusters
represent same genus and species observed three or more times within a unit. The data were
collected, and the comparisons were examined by creating frequency tables and percentage rates
to calculate for each factor. Incidence rates were the number of each device-associated infection
calculated for each month. The denominator was the population at risk, which was reflected in
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the device days. In the incidence rates for the study, I looked at the number of HAIs on a yearly
basis for 5-years. The SIR used NHSN data, which were comprised of observed (number of
infections) to the expected (expected number of infections) HAIs. For example the denominator
was the expected number of CLABSI for each location, which was calculated by multiplying the
location’s number of central line days by the NHSN rate and dividing by 1,000. The SIR is a
summary measure used to track HAIs at a national, state, or local level over time within each
population type. A SIR of 1.0 means the observed number of infections is equal to the number
that was expected or predicted using NHSN aggregate data. A SIR above 1.0 means the number
of infections observed in a particular unit is higher than what was predicted for that particular
population. By NHSN definition, if a patient has been classified for one device-associated
infection, the patient was not counted twice for other infections if the organism was the same
(See Appendix B for definitions). Conversely, each device-associated infection with a different
microorganism was counted as a separate infection (CDC, 2015a). These data were analyzed and
compared between three different types of ICUs. The aggregate NHSN national pooled mean of
similar patient populations in other academic medical centers in the United States was used to
compare the ICU populations for this academic medical center. The data for each ICU
population were derived from aggregate pooled means of comparable patient populations. The
SIR allows summarization of data within similar patient populations by adjusting for differences
in incidence in infections among the population/location types. The SIR adjusts for patients of
varying risk within each facility, which includes risk factors associated with different patient
populations. Data analysis included descriptive statistics; incidence infection rates; and
frequency distributions with tables, bar graphs, and/or charts using an Excel database, IBM SPSS
21, and Stata (IC 12.1 version).
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Study Population
The population for this study was adult male and female patients admitted to the three
ICUs (medical-surgical, cardiovascular, and neurosurgical) of a large acute care teaching
hospital within a period of 5 years, from 2010 – 2014. An official record of patients admitted
was obtained from TheraDoc, which is a data mining software that abstracts information from
EPIC, the electronic patient health record at the institution. Inclusion criteria included HAI (1-5)
and non-HAI patients (1-4):
1.

Patient must be adult male or female >18-years-old.

2.

Admitted to one of three ICUs (medical surgical, cardiovascular, and

neurosurgical) of the acute care teaching hospital between the time period of January 1,
2010–December 31, 2014.
3.

Length of stay in the acute care facility >2 days.

4.

Device used while hospitalized (central-line, Foley catheter, or ventilator).

5.

Met NHSN criteria for a device-related infection for CAUTI, CLABSI, and VAP

(Appendix B). The NHSN criteria is met by taking the number of device associated
infections for a given period divided by the number of device days for the same time
period for each ICU population.
There were three ICU types being evaluated in this study. The three units included a
medical-surgical ICU, cardiovascular ICU, and a neurosurgical ICU. Each ICU was analyzed
separately and compared to one another for similarities and differences. The total number of beds
for all combined intensive care units was 67. The investigation included any positive devicerelated HAI that was linked to the use of central lines, Foley catheters, and mechanical
ventilation. The denominator included the entire ICU populations who had devices in a given
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month. This included patients who had device associated HAIs and those at risk but without
device-associated infections. This enabled incidence rates to be developed. The study population
size included all patients identified as having a central line, Foley catheter, and/or on a ventilator
in a medical surgical ICU, cardiovascular ICU, and neurosurgical ICU during the 5-year period.
Each DAI identified was counted once, and there were no duplication of HAIs counted per
device according to NHSN criteria. For example, a patient may acquire a CLABSI, CAUTI,
and/or VAP. The NHSN guidelines and criteria were used when identifying all of the device
associated infections (Appendix B).
Data Collection
The research analyzed secondary data of all patients that were admitted to the three ICUs
from 2010–2014 extracted from Epic, a health information management system of medical
records. The data was validated by the Infection Prevention and Control Department of the acute
care research hospital using TheraDoc. The data analyzed was the number of device-related
infections and device days by month and year, demographics, patient APACHE score, and
microorganisms related to their infections. Patients with a device (central line, Foley catheter,
and/or ventilator) were (according to IC policy) to be monitored daily, along with monthly
evaluations of device utilization rates, infection incidence rates and SIRs. The utilization ratio for
central lines, Foley catheters and ventilators was estimated by month and year by the researcher.
This was done by taking the number of device days for each ICU. Device days were obtained by
counting the devices to estimate the total number of CLABSIs, CAUTIs, and VAPs among
patients in the ICUs, the infection prevention department used the total number of infections and
divided by the number of device days in order to obtain the infection rates per 1000 (Appendix
D). To calculate device utilization rates, the number of device days were divided by census days
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for each CLABSI, CAUTI, and VAP. The pooled mean for CLABSI, CAUTI, and VAP
infection rates were specific to each ICU and were obtained from the National Healthcare Safety
Network (NHSN). The guidelines used were from the NHSN (Appendix B) and were
implemented by both the ICUs and the Infection Prevention Department. Table 1 provides
information about which variables were used to answer each research question. The SIR is
calculated by determining the expected number which equals to the number of device days
multiplied by NHSN rate divided by 1000. The formula is Expected Number = Number of
Central Line Days x (NHSN Rate/1000). Once the expected number of infections is calculated,
the SIR calculation can be determined by using the Observed Number of infections divided by
the Expected Number of infections. The formula for SIR is: Observed/Expected.
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Table 1
Description of Variables Corresponding to Research Questions and Database Source
Research
Question

Dependent Variable

Independent Variable

# of CLABSI

Medical/Surgical ICU

# of CAUTI

Cardiovascular ICU

Source

Epic
RQ1

TheraDoc
# of VAP

Neurosurgical ICU
APACHE Score includes
Severity of Illness measured by:
temperature, mean arterial
pressure, heart rate, respiratory

CLABSI
RQ2

rate, oxygenation, arterial pH,

Epic

serum potassium, serum sodium,

Patient chart review

CAUTI
VAP
serum creatinine, hematocrit,
white blood cells count, coma
score, age, and chronic health;
obesity, diabetes, smoking
Healthcare-associated
Epic

RQ3

Infections (HAIs)

Age, gender, ethnicity, and race
TheraDoc

ICU type
Microorganisms
Types of HAI
RQ4

Gram-stain Genus/species

Epic

Susceptibility patterns

TheraDoc

# of HAI
ICU type
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Data Analysis
The Informatics Department from the Academic Medical Center provided de-identified
datasets for the purpose of this research. Information was abstracted from the limited dataset
needed for this research study. Data was downloaded to Excel from Epic and TheraDoc by the
Infection Prevention & Control Department personnel. A clarity report was created with a line
listing for each patient that was admitted into the ICUs during 2010 through 2014. All the
patients required information was included in the report. During the same admission, if a patient
had multiple microbiological cultures from the same source and same organism, the duplicate
patient listing was removed to prevent double counting. The academic medical center agreed to
provide the de-identified data from the Informatics Department, and therefore, there should not
have been a conflict of interest. The data was analyzed using SPSS software, version 21 and
Stata IC 12.1 version. Descriptive statistics, as frequencies, were used for categorical
demographic data (gender, race, and ethnicity). For this study American Indian/Alaska Native,
Asian, and Native Hawaiian or Other Pacific Islander were grouped into “Other” category for
Race and Ethnicity for data analysis purposes due to the small number of population within each
group. The mean age was calculated for each set of device-associated infections (CLABSI,
CAUTI, and VAP) and compared for differences. Setting parameters helped to standardize the
study into select age groups which was useful for comparing rates between population and
determining the severity of disease using the APACHE II scores. The APACHE II score uses a
standardized scoring system which can help to predict mortalities. Calculations were performed
with the HAI groups in this study. The HAI and non-HAI groups were further analyzed in regard
to their association with the following comorbidities: diabetes and obesity. Another risk factor
examined was smoking. The research population was adult male and female. Additionally,
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descriptive statistics such as frequencies were used for reporting microorganisms and
comorbidities within the known device associated HAI patients. As for the device-associated
infections, it was the average of infections per device days. The mean and the standard deviation
were used to compare the average and the measure of dispersion of device associated infections
between the three ICUs according to the NHSN data.
The research questions were analyzed as follows:
RQ#1: Is there a difference in the incidence rates of device-related nosocomial infections
between the different types of ICUs?
H01: There is no difference in the incidence rates of device-related nosocomial infections
between the different types of ICUs.
H11: There is a difference in the incidence rates of device-related nosocomial infections
between the different types of ICUs.
To determine the device (central-line, Foley catheter, or mechanical ventilator) which
increases the chances of an ill person in the ICU of developing an HAI, the device-related
infection incidence rates for CAUTI, CLABSI, and VAP were compared against the utilization
ratio in each ICU. Utilization ratio was calculated by dividing device days by patient days (the
number of patient in that unit daily). The utilization rate compared to the NHSN national pooled
mean provided a picture of how many intra-devices were being used on a particular unit in order
to determine over usage which can increase infections. Descriptive statistics as frequencies were
used for device types in each ICUs. To determine if infection rates were higher in one type of
ICU compared to other ICUs, the incidence rates and SIRs of CAUTI, CLABSI, and VAP in
each ICU were compared. To calculate the incidence rates of device associated HAIs in each
ICU, the number of cases was divided by device days multiplied by 1000 for each case identified
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per month and year. The device days for central-lines, Foley catheters, and mechanic ventilators
were calculated based on the number of patients with a device per day. To calculate device days,
the number of patients who had a device was recorded each day at the same time, and the daily
counts were added together at the end of the months. A SIR was determined by calculating the
number of observed cases divided by the number of expected infections. The number of expected
infections, known as the statistical prediction, is where each device associated infection such as
CLABSI, CAUTI, and VAP ratio was calculated using a standard population during a baseline
period. This period represented a standard population experience in each of the device associated
healthcare associated infection categories. The expected number of infections was calculated by
multiplying the number of device days by the NHSN pooled mean and dividing by 1000. The
pooled mean originates from a defined baseline report (Dudeck et al., 2011). The SIR was a
summary measure used to compare the hospital acquired infection (HAI) rate among one or more
groups of patients to the mean rate for the similar NHSN patient population. An SIR greater than
1.0 indicated that more HAIs were observed than predicted, and an SIR less than 1.0 indicated
that fewer HAIs were observed than predicted. The calculation of HAI rates for each device was
the number of hospital acquired infections divided by the number of device days multiplied by
1000 in order to obtain rates. The numerator was each identified case of device associated HAI
which occurred during the month. The denominator was the number of device days counted
during the day, at the same time, in each intensive care unit for each infection category (see
Table 2). Quarterly data were analyzed for the five year period (2010–2014) from the data
provided by Infection Prevention. The standard deviations for the rates were calculated, and the
mean was calculated yearly based on NHSN guidelines. The 50th percentile bar is a standard
provided by the NHSN for comparisons to the national average. The data were collected and the
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comparisons were done by creating rate tables and SIR for each device. To test for differences in
the infection rates and SIR by ICUs, analysis of variance (ANOVA) was used. Assumptions
were tested and met for ANOVA. Post-hoc analysis was done to determine where the ICUs
differed.
Table 2
Calculation of Device-related Healthcare Associated Infection Rates
Types of Device Associated Healthcare
Associated Infections

Calculations

Ventilator Rates

# VAP cases/# of ventilator device days x 1000

Foley Catheter UTI Rates

# CAUTI cases/# of FC device days x 1000

Central Line BSI Rates

# CLABSI cases/# of CL device days x 1000

RQ#2: What is the association between severity of illness, measured by the Acute
Physiology and Chronic Health Evaluation II (APACHE II) score, and CLABSI, CAUTI, and
VAP?
H02: There is no association between severity of illness (APACHE score) and CLABSI,
CAUTI, and VAP.
H12: There is an association between severity of illness (APACHE score) and CLABSI,
CAUTI, and VAP.
The research study utilized the Acute Physiology and Chronic Health Evaluation
(APACHE II) scoring system as a tool to determine the severity of a patient’s illness within the
first 24 hours of admission to the ICU (Knaus et al., 1985; Le Gall, 2005; Vincent & Moreno,
2010). The APACHE II scoring system is based on age, chronic health problems, and 12
physiologic variables (temperature, mean arterial pressure, heart rate, respiratory rate,
oxygenation, arterial pH, serum sodium, serum potassium, serum creatinine, hematocrit, white
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blood cells count, and Glasgow coma score for measure of neurologic function) (Knaus et al.,
1985; Vincent & Moreno, 2010). The APACHE scoring system was used to determine the
severity of illness and to abstract the data manually (Table 7-9). By quantifying the disease
severity upon admission to the ICUs, the study was able to identify the association between
patients’ conditions and device-related HAIs. Table 1 shows the components used to determine
severity of illness for research question 2.
APACHE II scores of patients admitted to the ICUs were calculated using a web-based
APACHE II analysis system. Descriptive statistics were used to analyze APACHE II scores by
computing the mean total score and standard deviation of patients with a device. To determine
the correlation between each of the device-associated HAIs (CAUTI, CLABSI, and VAP) and
APACHE II score, odds ratio and Chi-square analyses were used. To test for differences in
APACHE scores between patients who had CLABSI, CAUTI, and VAPs, analysis of variance
(ANOVA) was used.
RQ#3: What is the association between age, gender, race and ethnicity from the device
associated HAIs identified in the three different adult ICUs within an academic medical facility?
H03: There is no association between age, gender, race and ethnicity from the device
associated HAIs identified in the three different adult ICUs within an academic medical facility?
H13: There is an association between age, gender, race and ethnicity from the device
associated HAIs identified in the three different adult ICUs within an academic medical facility?
Descriptive statistics (frequencies) were used for categorical risk factors (age, gender,
race and ethnicity). To determine the association between categorical risk factors and acquiring
device-related HAI in the three ICUs, the frequencies of patients with devices who developed
HAIs and patients with devices who did not develop HAIs was compared using Chi-square
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statistics. The categories for age were divided into 18-29, 30-39, 40-49, 50-59, and ≥60 years of
age, and male and female for gender. Race and ethnicity were grouped by White/Caucasian,
Hispanic, Black/African-American, and Other. This categorization was used for race and
ethnicity consistent with the distribution utilized by the Texas Department of State Health
Services for disease distribution analysis.
RQ#4: Are there significant differences in the types of microorganisms (e.g. genus,
species and susceptibility according to the Clinical and Laboratory Standards Institute (Patel et
al., 2015) which are associated with device-related HAIs in three adult ICUs within an academic
medical facility?
H04: There are no significant differences in the types of microorganisms (e.g. genus,
species, and susceptibility according to the Clinical and Laboratory Standards Institute (Patel et
al., 2015) associated with device-related HAIs in three adult ICUs within an academic medical
facility.
H14: There are significant differences in the types of microorganisms (e.g. genus, species
susceptibility according to the Clinical and Laboratory Standards Institute (Patel et al., 2015)
which are associated with device-related HAIs in three adult ICUs within an academic medical
facility.
Descriptive statistics (frequencies and mean) were used to identify the different types of
microorganisms associated with each of the HAIs within the three ICUs. Analysis of variance
(ANOVA) was used to determine if there were differences in the types of microorganisms
associated with device-related HAIs within the three ICUs. Prior to the use of the data, the
assumptions were tested and conditions were met with the use of ANOVA. Additionally, for
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each categorical risk factor, the study identified the predominant microorganisms in patients that
develop device-related HAIs within the three ICUs.
Threats to Validity
The results of this research may help to establish association between the possible risk
factors (such as age, gender, race, and ethnicity), disease severity, device utilization, ICU types,
and HAIs. However, it was important to consider other variables that might affect the rate of
infections. Variables that might affect infection rates include comorbidities of individual patients
(see Table 10-17), varied ICU environments from year to year, and clinical staff turnover.
Utilizing a standardized acuity scoring system, using the same ICU units for the patient
population being studied may minimize possible sources of bias. Another threat to validity was
that the NHSN definitions of healthcare-associated infections are periodically updated from year
to year, which affects hospital staff in determining device-related infections, thus affecting the
data.
Ethical Procedures
The researcher conducting the study is knowledgeable in infection prevention and control
and has worked in an acute health care setting. Additionally, I manage the Infection Prevention
and Control Department in the acute care hospital. For this study, the researcher completed the
National Institute of Health “Protecting Human Research Participants” training course. Access to
hospital patient database was granted by the Vice President of Hospital Quality, who also serves
as the Hospital Chief Quality Officer (Appendix C). Patient data was de-identified and replaced
with a unique study identification number to maintain patient confidentiality and privacy. The
Academic Medical Center provided personnel from the Informatics Department to extract the
necessary data set for this study. The dataset contained a unique identifier for each patient. I only
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accessed patient information as a student according to HIPAA guidelines. The limited data set
was transferred into an Excel spreadsheet without patient identifiers. No experimental medical
procedures were performed for this research study. Since this was a retrospective study, future
patient admissions were not used. Data was secured on my personal computer to enable access
and data was not altered. De-identified data will be maintained for 5 years and then destroyed.
The research study was approved by the Walden University Institutional Review Board (IRB-0731-15-0151358) and the hospital Institutional Review Board (IRB-8843) prior to
implementation.
Summary
This historical prospective study used targeted surveillance to measure device associated
infections in three different ICUs by using the definitions of the NHSN. This research used a
quantitative historical prospective methods approach and was conducted at a University Medical
Center that included an initiative that was in line with a current organizational priority to reduce
the incidence of device associated HAI, such as CLABSI, CAUTI, and VAP. The target
population was all patients who had a positive confirmed healthcare associated infection with
central venous lines, Foley catheters, or on a ventilator in a medical surgical, cardiovascular, and
neurosurgical adult acute care intensive care unit. The measurement of device-associated
infection rates, incidence, microbiological pathogen profiles and risk factors were essential in
determining any patterns or trends within each ICU. The statistical analysis provided in Chapter
4 presents the necessary comparative tools to evaluate and examine the components of device
associated infections in the three different ICUs noted.
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Chapter 4: Results
Introduction
This research study was implemented in order to examine and compare device associated
nosocomial infections with three different ICUs within an academic medical hospital. I
compared multiple factors and attempted to compare incidence rates of device-related
nosocomial infections between three types of ICUs (cardiovascular, medical-surgical, and
neurosurgical) within an academic medical institution. The hypothesis was that there was no
difference in the incidence rates of device-related nosocomial infections between the three ICUs.
I also looked at the association between the severity of illness of patients, measured by the
APACHE II score, and CLABSI, CAUTI, and VAP. There was a statistically significant
difference in APACHE II scores of those who acquired device-associated infections between the
three ICUs (Tables 7-8). Furthermore, I examined the association between age, gender, race,
ethnicity, and HAI status of patients in the three adult ICUs. It was found that age, gender, race,
and ethnicity were not associated with an HAI (Tables 3 and 9). Finally, I looked for significant
differences in the types of microorganisms associated with device-related nosocomial infections
in the three adult ICUs. For Research Question 3, it was found that there was an association
between types of microorganisms associated with device-related HAIs in the three adult ICUs
within an academic medical facility (Tables 23-24). This chapter provides the results of the data
analysis conducted to answer the research questions related to HAIs within the three academic
ICUs studied.
Data Collection
I analyzed secondary data of all patients admitted to the three ICUs (cardiovascular,
medical-surgical, and neurosurgical) from 2010-2014 who developed a device-related
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nosocomial infection and those patients who did not develop a HAI. The data were extracted
from Epic, a health information management system of medical records and validated by the
infection prevention and control department at the academic medical center. This included
calculating APACHE II scores, identification of device-associated nosocomial infections,
identifying organisms, and capturing demographic data. Patient identifiers were removed prior to
obtaining the data for analysis, and numerical identifiers were assigned for each case to avoid
duplicate counts of the same HAI. The timeframe for data collection was 4 weeks. There were a
total of 321 patients identified as having device-related nosocomial infections; however, two
patients were excluded from the study because they did not meet the inclusion criteria due to age.
The research study was specific to the three ICUs within two hospitals of an academic medical
facility that serve surrounding areas including nearby states. There were a total of 4,213 patients
admitted to the three ICUs who met the inclusion criteria from 2010-2014, with an average age
of 59.13 (SD = 16.10). From 2010-2014, most patients were admitted to the medical-surgical
ICU (MSICU; 55.31%, n = 2,330), followed by the neurosurgical ICU (NSICU; 27.46%, n =
1,157). Over half of the study population were males (53.07%, n = 2,236); female: 46.93%, n =
1,977. The majority of the population were Caucasians (60.43%, n = 2,546), followed by African
Americans (25.30%, n = 1,066; Table 3). The population included all patients admitted to the
ICU within the 5-year study time frame that met the device-associated HAI criteria and those
who did not have an HAI.
Results
The demographics of patients who met criteria for the study were 60.43% Caucasian,
25.30% African American, 13.05% Hispanic or Latino, and 1.21% in other category (Table 3).
Most of the patients in the study were male (53.07%, n = 2,236) with the distribution being
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statistically significant at p < 0.001. The majority of patients who were admitted to the three
adult ICUs between 2010 and 2014 were ≥60 years of age (53.52%, n = 2,255) followed by 5059 years (21.55%, n = 908), 40-49 years (11.56%, n = 487), 30-39 years (7.24%, n = 305), and
18-29 years (6.12%, n = 258). Between 2010 and 2014, all patients who met the study inclusion
criteria were admitted to the medical-surgical ICU (55.31%, n = 2,330) followed by
neurosurgical ICU (27.46%, n = 1,157) and cardiovascular ICU (17.23%, n = 726). The majority
of patients who developed HAIs were Caucasians (65.52%, n = 209) followed by African
Americans (20.38%, n = 65), and Hispanic or Latino (10.66%, n = 34), being statistically
significant at p < 0.001; and these 319 HAI patients had a mean age of 58.49 (SD = 14.41), and
the non-HAI group had a mean of 59.19 (SD=16.23); however, the differences in age were not
statistically significant by the t-test (p = 0.455). Within the 5-year period, the majority of patients
identified with device-related nosocomial infections were in medical-surgical ICU (40.75%, n =
130), followed by neurosurgical (33.54%, n = 107), and cardiovascular ICU (25.71%, n = 82).
The distribution was statistically significant (p < 0.001).
With respect to the demographic and infection distribution in CVICU, most of the
patients were male (n = 437, 60.19%; Table 3). According to the chi-square test for gender and
patients with or without HAI, there was no statistically significant association found between
patients of either gender with an HAI and those without an HAI (p = 0.297). While most patients
were at least 60 years of age (n = 388, 53.44%), there was no statistically significant association
between patients of any age group with an HAI versus those without an HAI (p = 0.100). In
contrast, there was a statistically significant association between patients of any ethnicity without
an HAI and those with an HAI (p < 0.001). The majority of patients were Caucasian (n = 421,
57.99%), followed by African Americans (n = 194, 26.72%), Hispanic/Latino (n = 99, 13.64%),
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and all other racial/ethnic groups (n = 12, 1.65%); the distribution among the racial/ethnic
groups was statistically dissimilar (p < 0.001).
With respect to the demographic and infection distribution in MSICU, 54.03% of the
patients were male (n = 1,259; Table 3). According to the chi-square test for gender and patients
with or without HAI, the distribution was statistically dissimilar (p < 0.001). While 56.65%
patients were at least 60 years of age (n = 1,320), there was no significant association between
age group and the number of patients with or without HAI (p = 0.477). There were more
Caucasians (55.32%, n = 1,289) than any other racial/ethnic group: there were 676 African
Americans (29.01%), 335 Hispanics/Latinos (14.38%), and 30 for all else (1.29%). There was no
statistically significant association between racial/ethnic groups and the number of patients with
or without HAI (p = 0.138).
With respect to the demographic and infection distribution in NSICU, there were more
female patients (n = 617, 53.33%) than male patients (n = 540, 46.67%; Table 3). According to
the chi-square test for gender and patients with or without an HAI, there was no statistically
significant association (p = 0.069). While more patients aged at least 60 years had acquired an
HAI compared to other age groups (n = 40, 37.38%), there was no significant association
between the age of the patient and the number of patients with or without an HAI (p = 0.176).
Caucasians were the majority racial/ethnic group (n = 836, 72.26%), followed by African
Americans (n = 196, 16.94%), Hispanic/Latinos (n = 116, 10.03%), and all other race/ethnic
groups (n = 9, 0.78%). Although most patients who acquired an HAI were Caucasian (n = 73,
68.22%), the distribution between race and HAI status was statistically similar (p = 0.054).
Overall, HAIs increase as the patient’s age increases. The study did show that confounder of
HAI was age.
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Table 3
Demographics and Clinical Characteristics of Patients across Three Adult Intensive Care Units,
2010-2014
Demographic and Infection
Distribution

All Patients
(n = 4213)

Patients without
HAI (n = 3894)

Patients with
HAI (n = 319)

Sex -- n (%)

<0.001*

Male

2236 (53.07)

2101 (53.95)

135 (42.32)

Female**

1977 (46.93)

1793 (46.05)

184 (57.68)

Age -- n (%)

0.751

18-29

258 (6.12)

244 (6.27)

14 (4.39)

30-39

305 (7.24)

282 (7.24)

23 (7.21)

40-49

487 (11.56)

448 (11.50)

39 (12.23)

50-59
≥60

908 (21.55)
2255 (53.52)

837 (21.49)
2083 (53.49)

71 (22.26)
172 (53.92)

Race/Ethnicity† -- n (%)

<0.001*

African American

1066 (25.30)

1001 (25.71)

65 (20.38)

Caucasian

2546 (60.43)

2337 (60.02)

209 (65.52)

Hispanic or Latino

550 (13.05)

517 (13.25)

34 (10.66)

51 (1.21)

40 (1.03)

11 (3.45)

Other

P value

ICU Location -- n (%)

<0.001*

Cardiovascular (CVICU)

726 (17.23)

644 (16.54)

82 (25.71)

Medical-Surgical (MSICU)

2330 (55.31)

2200 (56.50)

130 (40.75)

Neurosurgical (NSICU)

1157 (27.46)

1050 (26.96)

107 (33.54)

Note. Chi-square test was used to obtain the p-values
†
Other category included American Indian/Alaska Native, Asian, and Native Hawaiian or Other Pacific Islander
* Statistically significant at p ≤ 0.05
** Females comprised 46.93% of all patients, however, females with HAI comprised 57.68%
Mean age for the 319 HAI patients was 58.49 (SD = 14.41), while those without an HAI had a mean age of 59.19
(SD = 16.23, n = 3,894). The mean age differences were not statistically significant p = 0.455 by t-test.
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Table 3 continued
Demographics and Clinical Characteristics of CVICU Patients, 2010-2014
CVICU
Demographic and
Infection Distribution
Sex -- n (%)
Male
Female
Age -- n (%)
18-29
30-39
40-49
50-59
≥60

All Patients

Patients
without HAI

Patients with
HAI

437 (60.19)
289 (39.81)

392 (60.87)
252 (39.13)

45 (54.88)
37 (45.12)

43 (5.92)
51 (7.02)
88 (12.12)
156 (21.49)
388 (53.44)

43 (6.68)
45 (6.99)
77 (11.96)
142 (22.05)
337 (52.33)

0 (0.00)
6 (7.32)
11 (13.41)
14 (17.07)
51 (62.20)

P value
0.297

0.102

Race/Ethnicity† -- n (%)
<0.001*
African American
194 (26.72)
182 (28.26)
12 (14.63)
Caucasian
421 (57.99)
366 (56.68)
56 (68.29)
Hispanic or Latino
99 (13.64)
90 (13.98)
9 (10.98)
†
Other
12 (1.65)
7 (1.09)
5 (6.10)
Note. Chi-squared tests were used to obtain the p-values
* Statistically significant at p ≤ 0.05
†
Other category included American Indian/Alaska Native, Asian, and Native Hawaiian or Other Pacific Islander

Table 3 continued
Demographics and Clinical Characteristics of MSICU Patients, 2010-2014
MSICU
Demographic and
Patients
Patients
Infection Distribution
All Patients
without HAI
with HAI
P value
Sex -- n (%)
<0.001*
Male
1,259 (54.03)
1,210 (55.00)
49 (37.69)
Female
1,071 (45.97)
990 (45.00)
81 (62.31)
Age -- n (%)
0.477
18-29
143 (6.14)
134 (6.09)
9 (6.92)
30-39
157 (6.74)
151 (6.86)
6 (4.62)
40-49
243 (10.42)
234 (10.64)
9 (6.92)
50-59
467 (20.04)
442 (20.09)
25 (19.23)
≥60
1,320 (56.65)
1,239 (56.32)
81 (62.31)
Race/Ethnicity† -- n (%)
0.138
African American
676 (29.01)
640 (29.09)
36 (27.69)
Caucasian
1,289 (55.32)
1,209 (54.95)
80 (61.54)
Hispanic or Latino
335 (14.38)
325 (14.73)
11 (8.46)
Other†
30 (1.29)
27 (1.23)
3 (2.31)
Note. Chi-squared tests were used to obtain the p-values
* Statistically significant at p ≤ 0.05
†
Other category included American Indian/Alaska Native, Asian, and Native Hawaiian or Other Pacific Islander
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Table 3 continued
Demographics and Clinical Characteristics of NSICU Patients, 2010-2014

NSICU
Demographic and
Infection Distribution

All Patients

Patients
without HAI

Patients
with HAI

Sex -- n (%)

P value
0.069

Male

540 (46.67)

499 (47.52)

41 (38.32)

Female

617 (53.33)

551 (52.48)

66 (61.68)

Age -- n (%)

0.176

18-29

72 (6.22)

67 (6.38)

5 (4.67)

30-39

97 (8.38)

86 (8.19)

11 (10.28)

40-49

156 (13.48)

137 (13.05)

19 (17.76)

50-59

285 (24.63)

253 (24.10)

32 (29.91)

≥60

547 (47.28)

507 (48.29)

40 (37.38)

Race/Ethnicity† -- n (%)

0.054

African American

196 (16.94)

179 (17.05)

17 (15.89)

Caucasian

836 (72.26)

763 (72.67)

73 (68.22)

Hispanic or Latino

116 (10.03)

102 (9.71)

14 (13.08)

†

Other
9 (0.78)
6 (0.57)
3 (2.80)
Note. Chi-squared tests were used to obtain the p-values
†
Other category included American Indian/Alaska Native, Asian, and Native Hawaiian or Other Pacific Islander

Research Question 1 and Hypothesis
RQ#1: Is there a difference in the incidence rates of device-related nosocomial infections
between the different types of ICUs?
H01: There is no difference in incidence rates of device-related nosocomial infections
between the different types of ICUs.
H11: There is a difference in the incidence rates of device-related nosocomial infections
between the different types of ICUs.
There were 204 identified Catheter-associated Urinary Tract Infections (CAUTI), 61
Central-line Bloodstream Infections (CLABSI), and 54 Ventilator-associated Pneumonias (VAP)
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(Table 5). It was found that from 2010 – 2014, CVICU had the highest incidence rate for
CLABSI (1.16 per 1000 CL days, sd = 0.56, range = 0.5 – 1.8) (Table 4). In 2012, CLABSI rates
were lowest for the three ICUs (Appendix D). However, the difference in CLABSI incidence
rates in the three ICUs was not statistically significant (p = 0.349) (Table 4). MSICU had the
highest CAUTI rate from 2010 – 2014 between the three ICUs (3.98 per 1000 Foley days, sd =
1.07, range = 2.6 – 5.1) (Table 4). However, CAUTI rates were lowest in 2014 for the three ICUs
(Figure 3). The difference in the CAUTI infection rate between the three ICUs was not
statistically significant (p = 0.187) (Table 4). NSICU had the highest incidence rate for ventilator
associated pneumonia (4.67 per 1000 vent days, sd = 3.60, range = 1.6 – 10.4) compared to other
ICUs with the highest rate being in 2010 (Table 4, Figure 4). A chi-square test shows that the
distribution of the VAP rate across the ICUs is statistically similar (p = 0.052) (Table 4);
however, a Pearson correlation has shown statistical significance for VAP rates specifically in
NSICU (Appendix D). If the study would have used a larger sample, there may have been
possible significance in the p value. In this study, NSICU patients were shown to have a higher
rate of developing a ventilator associated pneumonia than the other two ICUs. From this study it
can be concluded that neurologic disease may be a risk factor for VAP development. The
implication is that while the distribution of the VAP rate is statistically similar across the ICUs,
the VAP rate is correlated with the VAP rate within NSICU. Comparison of device associated
infection rates total in the three ICUs from 2010 to 2014 is seen in Figure 5.
In the 5-year period of 2010-2014, CVICU had the highest mean SIR for CLABSI
compared to the other two ICUs; however, the difference was not statistically significant (p =
0.136) (Table 5). The difference in mean SIRs for CAUTI in the three ICUs was statistically
significant (p = 0.027) (Table 5). In contrast, differences in VAP SIR across the ICUs were
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statistically insignificant (p = 0.096) (Table 5). The Bonferroni post-hoc analysis was used to
compare between the HAI groups because the post-hoc analysis test was flexible enough to be
used on any statistical test. Bonferroni post-hoc analysis revealed that the CAUTI SIR for
NSICU was statistically significant (p = 0.046; Table 5, Appendix E).
Table 6 shows the aggregated correlation between device utilization and device infection
rate in 2010-2014 across the three ICUs. The mean device infection rate (DIR) for CAUTI is
3.58 ± 1.02; for CLABSI is 0.92 ± 0.64; and for VAP is 1.75 ± 2.77. The mean device utilization
ratio (DUR, which is calculated by number of device days divided by the number of patient
days) for CAUTI is 0.61 ± 0.11; for CLABSI is 0.62 ± 0.16; and for VAP is 0.31 ± 0.06. CAUTI
has a Pearson correlation coefficient of 0.43, being statistically insignificant at p = 0.11.
Similarly, CLABSI has a 0.35 correlation coefficient that is statistically insignificant at p = 0.21.
Finally, the coefficient for VAP is -0.34 at p = 0.21. Overall, aggregating the information for the
three ICUs does not reveal a statistically significant association between a device-associated
infection and its infection rate nor its utilization ratio. The research compared the device
utilization rates in the five year period between the three ICUs (Figure 6, Appendix E). CVICU
had the highest central line utilization and ventilator utilization rates compared to other ICUs,
and their rate was above the NHSN national pooled mean (Figure 6). NSICU had the highest
CAUTI utilization rates compared to CVICU and MSICU, and the national pooled mean (Figure
6). However, utilization rates of any device were not correlated to device infection rates.
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Table 4
Incidence Rates of Device-related Nosocomial Infections in the Three ICUs, 2010 – 2014

CLABSI Rate

CAUTI Rate

VAP Rate

Location

Mean

CVICU
MSICU
NSICU
Total
CVICU
MSICU
NSICU

1.16
1.10
0.6
0.95
2.86
3.98
3.92

Std.
Deviation
0.56
0.41
0.87
0.65
1.24
1.07
0.61

Total
CVICU
MSICU

3.59
1.36
0.99

NSICU

4.67

Minimum

Maximum

p-value

0.5
0.6
0
0
1.5
2.6
3.2

1.8
1.5
1.9
1.9
4.6
5.1
4.6

0.349

1.08
1.54
0.91

1.5
0.50
0

5.1
4.10
2.44

3.60

1.60

10.4

0.187

Total
2.34
2.75
0
10.4
0.052
Note. Rates are calculated per 1000 device line days
Statistical significance tests performed with ANOVA
Pearson correlation demonstrates within ICU statistical significance (p ≤ 0.05) in NSICU with VAP rate
(Appendix D)

Table 5
Standardized Infection Ratio (SIR) of Device-related Nosocomial Infections in the Three ICUs,
2010 – 2014

CLABSI
SIR

CAUTI
SIR

VAP
SIR

Location

n

Mean
SIR

Std.
Deviation

Minimum

Maximum

CVICU
MSICU
NSICU
Total
CVICU
MSICU
NSICU††
Total
CVICU
MSICU
NSICU
Total

24
30
7
61
45
87
72
204
13
13
28
54

1.46
0.90
0.56
0.97
1.60
1.66
0.78
1.35
0.78
0.62
2.24
1.21

0.72
0.35
0.82
0.72
0.72
0.44
0.13
0.62
0.91
0.55
1.74
1.33

0.6
0.5
0
0
0.8
1.1
0.6
0.6
0.30
0
0.70
0

2.3
1.3
1.8
2.3
2.6
2.1
0.9
2.6
2.4
1.5
5
5

Note. †ANOVA shows significant difference in mean CAUTI SIR by unit location (p=0.027)
††
Significant difference based on Bonferroni post-hoc analysis within unit (p=0.046)

p-value

0.136

0.027†

0.096
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Comparison of ICU CLABSI Rate per 1000 CL Days
2010-2014
2

Rate of Infection/1000 CL Days

1.7
1.5
1.5
1.2
1.1
1

0.88

0.9

0.55

0.59

0.5

0
0
2010-2011

2012-2013

2014

Years
CVICU

MSICU

NSICU

Figure 2. Central-line associated bloodstream infection (CLABSI) rate over a period of 5 years
in three intensive care units.
The difference in CLABSI incidence rates in the three ICUs was not statistically significant (p =
0.349) as shown on Table 4.
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6

Comparison of ICU CAUTI Rates per 1000 Foley Days
2010-2014

5
4
3
2
1
0
MSICU
CVICU
NSICU

2010
5.1
3.2
3.4

2011
5.0
4.6
4.4

2012
3.8
3.2
4.6

2013
3.4
1.8
4.0

2014
2.6
1.5
3.2

Figure 3. Cather-associated urinary tract infection (CAUTI) rate over a period of 5 years in three
ICUs.
CAUTI infection rate was not statistically significant as shown by ANOVA (Table 5: p = 0.187).
Comparison of ICU VAP Rates per 1000 Vent Days
2010-2014
12.0

Rate of Infection

10.0
8.0
6.0
4.0
2.0
0.0
MSICU
CVICU
NSICU

2010
2.4
4.1
10.4

2011
0.8
0.6
5.0

2012
0.0
0.5
1.6

2013
0.6
1.0
4.7

2014
1.1
0.6
1.6

Figure 4. Ventilator-associated pneumonia (VAP) rate over a period of 5 years in three ICUs.
VAP rate difference was not statistically significant between the three ICUs as shown by
ANOVA (Table 4: p = 0.052).
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Rate Totals

ICU Device Associated Infection Rate Totals
2010-2014

10.0
9.0
8.0
7.0
6.0
5.0
4.0
3.0
2.0
1.0
0.0

4.6
0.95
1.4
4.1

2.9

3.9

1.1

1.1

0.6

MSICU

CVICU

NSICU

CLABSI TOTAL

CAUTI TOTAL

VAP TOTAL

Figure 5. Comparison of device associated infection rates per 1000 device line days in the three ICUs
from 2010-2014
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Figure 6. Device utilization rates in the three ICUs from 2010-2014 compared to NHSN national utilization
rates pooled mean

72

Table 6
Correlation between Device Utilization and Device Infection Rate across the ICUs, 2010-2014

Device Infection Rate
Device
Associated
Infection

Device Utilization
Ratio (DUR)*
Pearson
correlation

p-value

Mean

Standard
Deviation

Mean

Standard
Deviation

CAUTI

3.58

1.02

0.61

0.11

0.43

0.11

CLABSI

0.92

0.64

0.62

0.16

0.35

0.21

VAP

1.75

2.77

0.31

0.06

-0.34

0.21

Note. *DUR is calculated by number of device days/number of patient days

Research Question 2 and Hypothesis
RQ#2: What is the association between severity of illness, measured by the Acute
Physiology and Chronic Health Evaluation II (APACHE II) score, and CLABSI, CAUTI, and
VAP?
H02: There is no association between severity of illness (APACHE score) and CLABSI,
CAUTI, and VAP.
H12: There is an association between severity of illness (APACHE score) and CLABSI,
CAUTI, and VAP.
The mean severity of illness score for the patients identified with an HAI was 20.99 (SD
= 8.71) with possible score of 71 indicating the most severe condition of a patient within 24
hours of admission within the intensive care unit (Table 7). The mean score for non-HAI patients
was 20.67 ± 7.88 (Table 7). APACHE II scores among Non-HAI patients were similar across all
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3 ICU types. Aggregating all three ICUs has led to a statistically insignificant association
between the APACHE II score of patients who did and did not acquire a device associated
nosocomial infection (p = 0.494) (Table 7). Disaggregating the ICUs, patients who acquired
VAP in all three ICUs combined had highest mean APACHE score compared to those who
acquired CAUTI and CLABSI; however, the difference in mean APACHE scores between the
three types of device associated infections was not statistically significant (p=0.333) (Table 8).
Those who were admitted to CVICU had a higher mean score (23.22 ± 8.67) than the patients
without an HAI (20.51 ± 7.94) (p = 0.004). Similarly, patients in the MSICU with an HAI had a
higher mean score (23.15 ± 8.72) than the non-HAI patients (20.76 ± 7.92) (p < 0.001) (Table 7).
In contrast, the HAI APACHE II scores (16.65 ± 7.01) (p < 0.001) were significantly lower than
the Non-HAI APACHE II scores (20.58 ± 7.74) among NSICU patients (Table 7). As such, there
were unit-level statistical significant associations (pCVICU = 0.004, pMSICU < 0.001, and pNSICU
<0.001), revealing that the aggregation has masked significant differences.
There were statistically significant differences in mean APACHE scores between the
units for each HAI type when analyzing each ICU individually (Table 8). For CAUTI, CVICU
had a mean score of 23.11 ± 8.53, MSICU had 22.51 ± 8.03, and NSICU had 16.29 ± 7.15 (p <
0.001). For CLABSI, CVICU had a mean score of 20.54 ± 9.21, MSICU had 24.13 ± 11.17, and
NSICU had 14.00 ± 3.79 (p = 0.048). For VAP, CVICU had a mean score of 28.54 ± 5.75,
MSICU had 25.15 ± 6.64, and NSICU had 18.25 ± 7.12 (p < 0.001). For non-device-associated
infections, the mean APACHE score was 20.67 ± 7.88; however, their distribution among the
ICUs was statistically similar (p < 0.708).
Across all infections, there statistically significant differences in the distribution for each
ICU (Table 8). In the CVICU, the total mean APACHE score for every infection (including non-
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infection) was 20.82 ± 8.07 (p < 0.001). In the MSICU, the total mean score was 20.89 ± 7.99 (p
= 0.005). In the NSICU, the total mean score was 20.21 ± 7.76 (p < 0.001). Thus, similarly to the
results of Table 7, the implications are that aggregating the ICUs dilutes significant differences,
whereas associations exists at the unit level and infection level.
Table 7
Comparison of Mean APACHE II Scores Between HAI and Non-HAI Patients Within and Across
Three ICU Units, 2010-2014
Without HAI

With HAI

N

Mean
APACHE
Score ± sd

N

Mean
APACHE
Score ± sd

Cardiovascular ICU (CVICU)

644

20.51 (±7.94)

82

23.22 ± 8.67

0.004*

Medical Surgical ICU
(MSICU)

2200 20.76 (±7.92)

130

23.15 ± 8.72

<0.001*

Neurosurgical ICU (NSICU) †

1050 20.58 (±7.74)

107

16.65 ± 7.01

<0.001*

Total

3894 20.67 (±7.88)

319

20.99 (± 8.71)

Unit Location

P-value
from ttest

0.494†

Note. *Statistically significant at p ≤ 0.05.
†
Significant difference of APACHE II scores based on Bonferroni post-hoc analysis in NSICU (p < 0.001)
††
ANOVA results reveal a significant difference of APACHE II scores between ICU units (p < 0.001). Differences
in mean scores are statistically significant even when controlling for age and sex (p < 0.001).
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Table 8
Severity of Illness of ICU Patients within the Three ICUs which were Measured by the Acute
Physiology and Chronic Health Evaluation II (APACHE II) Score in 2010-2014
Unit

CVICU
Type of Deviceassociated
Infections

Catheter Associated
Urinary Tract
Infection (CAUTI)

Central Line
Associated
Bloodstream
Infection (CLABSI)

Ventilator
Associated
Pneumonia (VAP)

No Deviceassociated
Infections

Total

p-value from
ANOVA

Mean
APACHE
Std. Deviation
N

MSICU

P-value
from
ANOVA

NSICU

Mean APACHE Mean APACHE
Std. Deviation
Std. Deviation
N
N

Total

23.11

22.51

16.29

20.45

8.53
45

8.03
87

7.15
72

8.40
204

20.54

24.13

14.00

21.56

9.21
24

11.17
30

3.79
7

10.23
61

28.54

25.15

18.25

22.39

5.75
13

6.64
13

7.12
28

7.97
54

20.51

20.76

20.58

20.67

7.94
645

7.93
2,201

7.74
1,050

7.88
3,894

20.82
8.07
727

20.89
7.99
2,331

20.21
7.76
1,157

20.69
7.94
4,213

<0.001*

0.005*

<0.001*

<0.001*

0.048*

<0.001*

0.708

0.333†

Note. *Statistically significant at p ≤ 0.05.
†
ANOVA has revealed further insignificant difference in mean APACHE score across the ICUs when controlling for
age and sex (p = 0.262). NSICU have HAI patients with significantly lower APACHE II scores.

76

For individuals without risk factors (i.e. those without obesity, smoking habits, and
diabetes) in each of the ICUs, an ANOVA reveals statistically significant differences in mean
APACHE II scores between those without an HAI and those with an HAI for some subgroups of
the sample as shown in Table 9. In the CVICU, the mean APACHE II score for male patients
without an HAI is 19.80 ± 6.14, while male patients with an HAI have a mean score of 24.82 ±
6.98; and the difference in the means is statistically significant (p = 0.013). Additionally, the
differences in the mean scores for those aged 60 and over are statistically significant (p = 0.002):
the mean score of non-HAI patients aged at least 60 years is 19.41 ± 6.46 and the mean score for
those with HAI for the same age group is 26.78 ± 6.14. The mean APACHE II score for
Caucasian patients without an HAI is 19.36 ± 6.15, while Caucasian patients with an HAI have a
mean APACHE II score of 25.80 ± 6.86. The differences in the mean APACHE scores are
statistically significant (p = 0.002).
In the MSICU, female patients with an HAI (21.97 ± 8.62) have a statistically higher
mean score than female patients without an HAI (19.96 ± 6.03) at p = 0.093. There is no
statistically significant differences in mean APACHE score between male patients with and
without an HAI in the MSICU (21.67 ± 3.79 vs. 20.03 ± 6.04, p = 0.640). As with CVICU
Caucasian patients, there is a statistically significant difference in MSICU Caucasian patients
with an HAI (21.67 ± 8.03) and without an HAI (19.97 ± 5.87) with p = 0.035.
Finally, for the NSICU, female patients without an HAI have a higher mean APACHE II
score (18.76 ± 5.63) than female patients with an HAI (14.04 ± 8.48) at p ≤ 0.001. With respect
to age groups in the NSICU, there are statistically significant differences in mean APACHE II
scores for those aged 18-29 (18.25 ± 6.38 without HAI vs. 14.04 ± 8.48 with HAI, p = 0.003)
and those aged 50-59 (19.28 ± 5.57 without HAI vs. 12.91 ± 6.85 with HAI, p = 0.001). African
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American NSICU patients are also found to have statistically significant different mean
APACHE II scores (19.49 ± 4.98 without HAI vs. 10.40 ± 8.17 with HAI) at p = 0.001, as well
as Hispanic/Latino patients (18.88 ± 5.45 without HAI vs. 10.00 ± 5.20 with HAI) at the same pvalue of 0.001. Overall, the severity of illness for HAI patients entering into the neurosurgical
ICU were lower, possibly due to the patient population comorbidities which were not as high as
patients entering into the CVICU or MSICU.
In turn, patients without any risk factors were likely more at risk of contracting an HAI in
CVICU and MSICU, but not at NSICU, which may be due to unobserved factors in the NSICU
that is unaccounted in the data such as quality of care and medical history of the patient. CVICU
and MSICU had HAI patients with significantly higher APACHE scores, as compared to the
significantly lower APACHE scores for NSICU. Due to their more severe comorbidities, patients
admitted to either MSICU or CVICU have a higher severity of illness. Neurological patients
have lower mortality rates and are apt to have better outcomes than other types of ICUs due to
their lower number of comorbidities as demonstrated by their lower APACHE II scores (Kurtz et
al., 2011) (Table 7).
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Table 9
Severity of Illness as Measured by APACHE II across the ICUs, 2010-2014 by
Demographics (without Risk Factors)
Mean APACHE
Score (SD)
No HAI

Mean APACHE Score
(SD)
with HAI

N**

P-value (ANOVA)

Female
Male

18.87 (5.85)
19.80 (6.14)

22.67 (3.21)
24.82 (6.98)

79
108

0.357
0.013

18-29
30-39
40-49
50-59
≥60

18.42 (3.82)
20.70 (3.56)
19.77 (6.49)
19.08 (5.87)
19.41 (6.46)

17.00 (2.83)
22.00 (0.00)
22.00 (5.66)
26.78 (6.14)

12
12
27
41
95

0.802
0.739
0.496
0.002*

Ethnicity/Race
Caucasian
African American
Hispanic or Latino

19.36 (6.15)
19.85 (6.17)
18.73 (5.11)

25.80 (6.86)
18.50 (0.71)
22.00 (0.00)

114
49
23

0.002*
0.761
0.538

16.00 (0.00)

24.00 (0.00)

2

-

Female
Male

19.96 (6.03)
20.03 (6.04)

21.97 (8.62)
21.67 (3.79)

323
359

0.093
0.640

18-29
30-39
40-49
50-59
≥60

20.45 (6.85)
20.08 (6.18)
20.03 (5.92)
19.76 (5.60)
20.02 (6.14)

23.75 (4.03)
20.50 (16.26)
20.75 (10.75)
21.50 (8.40)
22.19 (8.49)

35
50
67
137
393

0.357
0.0931
0.824
0.410
0.175

Ethnicity/Race
Caucasian
African American
Hispanic or Latino

19.97 (5.87)
20.12 (6.30)
19.80 (6.35)

21.67 (8.03)
18.00 (9.51)
25.25 (7.89)

391
186
95

0.035*
0.427
0.099

19.00 (6.02)

27.33 (7.23)

11

0.083

Female
Male

18.76 (5.63)
19.13 (6.06)

14.04 (8.48)
16.91 (4.70)

157
145

≤0.001*
0.238

18-29
30-39
40-49
50-59
≥60

18.25 (6.38)
19.80 (4.97)
19.68 (5.88)
19.28 (5.57)
18.54 (6.04)

5.67 (3.06)
17.33 (5.51)
15.86 (11.04)
12.91 (6.85)
18.27 (4.56)

27
23
41
80
131

0.003*
0.437
0.192
0.001*
0.886

Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other

18.83 (6.10)
19.49 (4.98)
18.88 (5.45)
19.00 (0.00)

17.23 (7.13)
10.40 (8.17)
10.00 (5.20)
22.00 (0.00)

218
50
32
2

0.253
0.001*
0.001*
-

Unit
CVICU
Gender

Age Group

Other
MSICU
Gender

Age Group

Other
NSICU
Gender

Age Group

Note. *Statistically significant at p ≤ 0.05.
The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI patients,
HAI patients, or both
**N represents the Total for both HAI and Non-HAI patients for each unit.
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For patients with diabetes only (i.e. those with diabetes but do not have obesity nor
smoking habits), an ANOVA has revealed statistically significant differences in mean APACHE
II scores for only two groups: African American patients in the CVICU and MSICU patients
aged 50-59 in Table 10. African American CVICU patients without an HAI have a mean
APACHE II score of 28.92 ± 3.25 in comparison to those with an HAI of mean APACHE II
score of 15.00 (p = 0.001), while MSICU patients aged 50-59 without an HAI possess a mean
APACHE II score of 23.61 ± 7.75 in relation to those with an HAI having a mean score of 6.00
(p = 0.032). Low sample sizes for patients with only diabetes may have contributed to statistical
insignificance in many of the subpopulations for each ICU.
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Table 10
Severity of Illness as Measured by APACHE II across the ICUs, 2010-2014 by Demographics
(Patients with only Diabetes)
Unit

Mean APACHE Score
(SD)
No HAI

Mean APACHE Score
(SD)
with HAI

N

P-value
(ANOVA)

25.50 (8.22)
23.19 (9.83)

16.00 (0.00)
22.00 (9.90)

17
39

0.290
0.869

11.67 (9.81)
28.00 (6.24)
20.33 (12.50)
26.10 (11.00)
24.26 (8.33)

29.00 (0.00)
15.50 (0.71)

3
3
4
10
36

0.609
0.151

21.61 (9.87)
28.92 (3.25)
24.44 (11.22)
-

16.00 (0.00)
15.00 (0.00)
29.00 (0.00)
-

32
14
10
-

0.580
0.001*
0.710
-

25.56 (7.74)
23.27 (9.35)

23.58 (8.13)
31.33 (2.52)

59
81

0.426
0.142

24.33 (9.07)
24.00 (12.03)
23.46 (11.11)
23.61 (7.75)
24.72 (8.34)

26.00 (0.00)
35.00 (0.00)
6.00 (0.00)
25.82 (6.43)

8
12
13
34
85

0.814
0.402
0.032*
0.676

23.85 (9.16)
25.34 (7.98)
22.93 (9.38)
23.00 (0.00)

22.00 (8.91)
28.80 (6.06)
28.50 (3.54)
-

82
52
17
1

0.588
0.353
0.430
-

24.11 (9.02)
25.00 (8.00)

12.00 (7.07)
-

46
31

0.352
-

21.25 (12.69)
25.13 (9.00)
24.40 (7.88)
25.17 (9.49)
24.49 (8.34)

18.00 (7.07)

4
8
10
12
43

0.288

23.65 (8.82)
27.50 (6.94)
24.86 (9.28)
-

13.00 (0.00)
23.00 (0.00)
-

55
15
7
-

0.237
0.542
-

CVICU
Gender
Female
Male
Age Group
18-29
30-39
40-49
50-59
>60
Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other
MSICU
Gender
Female
Male
Age Group
18-29
30-39
40-49
50-59
>60
Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other
NSICU
Gender
Female
Male
Age Group
18-29
30-39
40-49
50-59
>60
Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other

Note. The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI
patients, HAI patients, or both.
**N represents the Total for both HAI and Non-HAI patients for this specific Unit.
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For people with smoking habits only (i.e. those with smoking habits but do not have
obesity nor diabetes), an ANOVA reveals statistically significant differences in mean APACHE
scores between those who have and do not have an HAI for some groups in each of the ICUs in
Table 11. In the CVICU, male patients without an HAI were found to have a lower mean
APACHE II score (20.43 ± 8.52) than male patients with an HAI (26.78 ± 7.40), being
statistically different at p = 0.033. In contrast, the mean scores between female CVICU patients
with and without an HAI do not have a statistically significant association (p = 0.622). In the
MSICU, patients aged 50-59 have a statistically significant difference in mean APACHE II
scores between those without and with an HAI (20.49 ± 7.78 vs. 30.67 ± 14.57) respectively at p
= 0.032. In the NSICU, patients aged 40-49 without an HAI have a higher mean APACHE II
score (19.91 ± 6.60) than those with an HAI (13.29 ± 3.40), being statistically significant at p =
0.014. Caucasian NSICU patients have a statistically significant difference in mean APACHE II
scores between those without and with an HAI (20.84 ± 7.56 vs. 17.94 ± 7.94) respectively at p =
0.047. Thus, patients with only smoking habits (i.e. no other risk factors) were likely more at risk
of contracting an HAI in CVICU and MSICU, but not at NSICU, which may be due to
unobserved factors in the NSICU that are unaccounted for in the data such as quality of care and
medical history of the patient.
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Table 11
Severity of Illness as Measured by APACHE II across the ICUs, 2010-2014 by
Demographics (Only Patients with Smoking Habits)
Unit

Mean APACHE Score
(SD)
No HAI

Mean APACHE Score
(SD)
with HAI

N**

P-value
(ANOVA)

CVICU
Gender
Female
Male
Age Group
18-29
30-39
40-49
50-59
≥60
Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other
MSICU
Gender
Female
Male
Age Group
18-29
30-39
40-49
50-59
≥60
Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other
NSICU
Gender
Female
Male
Age Group
18-29
30-39
40-49
50-59
≥60
Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other

19.53 (6.21)
20.43 (8.52)

20.67 (7.14)
26.78 (7.40)

60
111

0.622
0.033*

18.20 (6.01)
17.33 (5.91)
19.68 (9.17)
17.85 (7.00)
21.95 (7.90)

22.00 (0.00)
20.33 (9.45)
24.57 (7.78)

10
13
36
90

0.464
0.569
0.255

20.95 (7.84)
19.02 (7.12)
19.71 (9.19)
21.50 (7.78)

22.64 (7.61)
21.00 (4.24)
34.00 (0.00)

91
52
4

0.457
0.670
0.151

20.55 (7.89)
20.20 (7.90)

20.00 (4.58)
23.27 (9.16)

230
302

0.878
0.147

18.93 (7.45)
19.37 (7.07)
19.11 (6.79)
20.49 (7.78)
20.81 (8.24)

20.00 (0.00)
30.67 (14.57)
21.06 (6.51)

30
95
312

0.889
0.032*
0.906

20.82 (7.97)
19.51 (7.73)
20.32 (7.93)
15.20 (2.05)

22.62 (9.00)
24.50 (4.32)
8.00 (0.00)
-

313
140
74
-

0.431
0.119
0.127
-

20.70 (8.00)
21.29 (7.62)

17.57 (6.61)
18.19 (8.26)

169
151

0.089
0.129

19.55 (5.86)
22.24 (8.38)
19.91 (6.60)
21.10 (7.81)
21.17 (8.28)

20.00 (2.83)
13.00 (8.49)
13.29 (3.40)
17.45 (7.63)
20.60 (7.81)

22
27
41
83
147

0.917
0.146
0.014*
0.152
0.798

20.84 (7.56)
22.31 (8.45)
19.56 (8.58)
23.00 (0.00)

17.94 (7.64)
17.00 (1.41)
16.33 (8.14)
21.00 (0.00)

237
51
30
2

0.047*
0.384
0.541
-

Note. *Statistically significant at p ≤ 0.05.
The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI patients, HAI patients,
or both

**N represents the Total for both HAI and Non-HAI patients
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For individuals with obesity only (i.e. those with obesity but do not have smoking habits
nor diabetes) (Table 12), an ANOVA has revealed statistical significance in mean APACHE II
scores for NSICU male patients: 24.31 ± 9.92 for male patients without an HAI and 12.83 ± 3.19
for male patients with an HAI (p = 0.007). Because many other demographic groups in each ICU
did not have statistically significant associations with contracting an HAI, obesity by itself may
act as a weak confounding factor.
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Table 12
Severity of Illness as Measured by APACHE II across the ICUs, 2010-2014 by
Demographics (Patients with only Obesity)
Mean APACHE
Score (SD)
No HAI

Mean APACHE
Score (SD)
with HAI

N**

P-value
(ANOVA)

Female
Male

22.36 (8.60)
23.74 (10.07)

15.75 (10.75)
20.50 (12.02)

32
36

0.172
0.664

18-29
30-39
40-49
50-59
≥60

26.00 (4.24)
22.71 (6.97
21.50 (7.73)
24.00 (12.11)
23.20 (9.45)

13.75 (10.44)
24.50 (6.36)

2
7
16
16
27

0.132
0.851

23.00 (10.37)
23.75 (8.70)
22.11 (7.69)
-

18.40 (11.04)
12.00 (0.00)
-

38
21
9
0

0.365
0.203
-

24.02 (9.40)
24.41 (10.12)

24.89 (11.71)
27.17 (9.70)

130
134

0.792
0.516

24.18 (10.11)
22.11 (9.32)
27.52 (8.38)
24.29 (9.81)
23.68 (10.02)

27.00 (4.24)
26.00 (11.31)
30.67 (6.66)
20.33 (18.82)
25.60 (10.95)

19
20
36
48
141

0.707
0.587
0.533
0.523
0.676

23.29 (9.32)
24.17 (10.15)
27.57 (10.55)
26.00 (6.93)

26.60 (11.42)
22.33 (13.20)
27.00 (4.24)
-

143
78
37
6

0.288
0.761
0.940
-

22.56 (9.55)
24.31 (9.92)

20.00 (7.37)
12.83 (3.19)

78
54

0.467
0.007*

19.43 (10.98)
22.31 (11.40)
24.67 (11.20)
23.38 (9.78)
23.65 (9.14)

17.00 (8.45)
19.00 (7.94)
10.00 (1.41)
18.40 (6.02)

7
17
12
28
68

0.407
0.443
0.069
0.213

23.06 (9.54)
24.88 (11.79)
22.25 (7.09)
-

19.38 (7.71)
15.25 (3.86)
10.50 (2.12)
-

101
21
10
0

0.290
0.129
0.057
-

Unit
CVICU
Gender

Age Group

Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other
MSICU
Gender
Female
Male
Age Group
18-29
30-39
40-49
50-59
≥60
Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other
NSICU
Gender
Female
Male
Age Group
18-29
30-39
40-49
50-59
≥60
Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other

Note. *Statistically significant at p ≤ 0.05.
The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI patients,
HAI patients, or both
**N represents the Total for both HAI and Non-HAI patients for this specific unit
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For patients with both smoking habits and diabetes but do not have obesity (Table 13),
only two groups are found to have statistically significant differences in mean APACHE II
scores between those with and without an HAI: male MSICU patients (30.75 ± 11.15 with HAI
vs. 19.71 ± 8.68 without HAI, p = 0.015) and Caucasian MSICU patients (28.71 ± 8. 71 with
HAI vs. 18.97 ± 8.62 without HAI, p = 0.005). Because of the inconsistency in statistical
significance across the ICUs for each of the demographic groups, there may exist unobserved
aspects of the individual ICUs for which are not accounted in the data that could aid in
explaining differences in statistical significance. Nonetheless, for what is provided, there is a
noticeable indication that patients who both have diabetes and smoking habits (but do not have
obesity) may be at more risk of contracting an HAI.
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Table 13
Severity of Illness as Measured by APACHE II by ICU Type, 2010-2014 by Demographics (Patients
with both Smoking Habits and Diabetes)
Unit

Mean APACHE Score (SD)
No HAI

Mean APACHE Score (SD)
with HAI

N**

P-value
(ANOVA)

CVICU
Gender
Female
20.00 (7.53)
23.75 (4.99)
27
0.350
Male
20.32 (9.22)
19.13 (9.42)
42
0.743
Age Group
18-29
22.17 (9.22)
6
30-39
22.00 (8.49)
17.00 (0.00)
3
0.715
40-49
19.00 (12.12)
28.00 (0.00)
4
0.586
50-59
19.46 (7.42)
13.00 (0.00)
14
0.418
≥60
20.12 (8.94)
21.11 (8.84)
42
0.770
Ethnicity/Race
Caucasian
20.97 (9.15)
21.67 (9.12)
42
0.840
African American
20.00 (8.30)
13.00 (0.00)
16
0.428
Hispanic or Latino
18.38 (6.50)
17.00 (0.00)
9
0.848
Other
12.00 (0.00)
23.00 (0.00)
2
MSICU
Gender
Female
20.00 (9.07)
24.00 (6.04)
81
0.335
Male
19.71 (8.68)
30.75 (11.15)
118
0.015*
Age Group
18-29
21.56 (8.46)
18
30-39
17.82 (8.17)
11
40-49
17.82 (8.09)
22
50-59
19.00 (7.68)
32.00 (0.00)
40
0.103
≥60
20.50 (9.50)
26.38 (9.20)
108
0.095
Ethnicity/Race
Caucasian
18.97 (8.62)
28.71 (8.71)
97
0.005*
African American
21.69 (8.93)
21.00 (8.49)
64
0.914
Hispanic or Latino
18.29 (8.72)
35
Other
25.00 (9.54)
3
NSICU
Gender
Female
19.31 (7.79)
18.00 (8.49)
54
0.817
Male
21.17 (7.71)
16.60 (3.21)
53
0.198
Age Group
18-29
17.50 (13.44)
2
30-39
20.83 (8.30)
12.00 (0.00)
7
0.370
40-49
20.74 (8.03)
19
50-59
22.48 (8.47)
17.67 (6.03)
24
0.357
≥60
19.12 (7.22)
18.00 (2.65)
55
0.793
Ethnicity/Race
Caucasian
20.41 (7.78)
15.80 (3.83)
73
0.195
African American
17.63 (6.61)
16.00 (0.00)
17
0.815
Hispanic or Latino
21.88 (8.59)
16
Other
24.00 (0.00)
1
Note. *Statistically significant at p ≤ 0.05.
The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI patients, HAI patients, or
both.
**N represents the Total for both HAI and Non-HAI patients for this specific unit.
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For people with both obesity and diabetes but do not have smoking habits (Table 14), an
ANOVA shows that there exists statistical significant differences in mean APACHE II scores in
CVICU and MSICU patients. In the CVICU, patients aged 50-59 without an HAI have a lower
mean score (18.10 ± 3.81) than those with an HAI (28.50 ± 12.02), being statistically significant
at p = 0.028. African American CVICU patients have a higher mean APACHE II score (37.00)
than the same patients without an HAI (19.30 ± 5.60), being statistically significant at p = 0.015.
In the MSICU, patients aged 50-59 have a higher mean APACHE II score (36.00) than the same
patients without an HAI (20.70 ± 6.46), being statistically significant at p = 0.030.
Hispanic/Latino MSICU patients with an HAI possess a higher mean score of 36.00 than those
without an HAI (18.79 ± 3.08) (p < 0.001). Although low sample sizes for patients with an HAI
in each of the ICUs are a major possible factor in producing statistically insignificance for many
of the subpopulation groups, statistical significance in the two ICUs may indicate that the
interaction of obesity and diabetes may subject patients to be more at risk of contracting an HAI.
Prior research has found that patients with obesity and diabetes are more vulnerable to HAIs
(Masud & Vykoukal, 2011).
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Table 14
Severity of Illness as Measured by APACHE II by ICU Type, 2010-2014 by Demographics
(Patients with both Obesity and Diabetes)
Unit

Mean APACHE Score (SD)
No HAI

Mean APACHE Score (SD)
with HAI

N**

P-value
(ANOVA)

CVICU
Gender
Female
20.40 (7.41)
27.83 (10.07)
21
0.076
Male
22.31 (6.68)
25.50 (10.61)
28
0.532
.
Age Group
18-29
22.00 (8.29)
4
30-39
26.33 (11.55)
3
40-49
20.00 (0.00)
1
50-59
18.10 (3.81)
28.50 (12.02)
12
0.028*
≥60
22.52 (7.08)
26.83 (9.79)
29
0.230
Ethnicity/Race
Caucasian
22.38 (7.10)
24.00 (8.65)
30
0.634
African American
19.30 (5.60)
37.00 (0.00)
11
0.015*
Hispanic or Latino
24.20 (8.70)
37.00 (0.00)
6
0.250
Other
17.50 (6.36)
2
MSICU
Gender
Female
20.66 (5.59)
21.29 (9.62)
71
0.795
Male
21.40 (6.26)
22.00 (0.00)
74
0.924
Age Group
18-29
23.14 (6.89)
7
30-39
16.60 (4.93)
26.00 (0.00)
6
0.157
40-49
23.08 (6.17)
13
50-59
20.70 (6.46)
36.00 (0.00)
24
0.030*
≥60
20.93 (5.70)
18.17 (7.19)
95
0.261
Ethnicity/Race
Caucasian
21.77 (6.51)
22.00 (4.00)
89
0.951
African American
20.57 (5.48)
17.25 (8.96)
34
0.300
Hispanic or Latino
18.79 (3.08)
36.00 (0.00)
20
<0.001*
Other
19.00 (1.41)
2
NSICU
Gender
Female
20.63 (6.17)
20.00 (0.00)
31
0.920
Male
20.73 (6.52)
30
Age Group
18-29
27.50 (7.78)
2
30-39
19.25 (9.46)
4
40-49
19.69 (4.59)
20.00 (0.00)
14
0.950
50-59
22.67 (7.09)
15
≥60
19.73 (5.85)
26
Ethnicity/Race
Caucasian
20.32 (6.04)
41
African American
21.80 (6.86)
20.00 (0.00)
11
0.808
Hispanic or Latino
20.57 (6.16)
7
Other
23.00 (14.14)
2
Note. *Statistically significant at p ≤ 0.05.
The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI patients, HAI patients, or
both.

**N represents the Total for both HAI and Non-HAI patients for this specific unit.
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For individuals with both obesity and smoking habits (i.e. those who do not have
diabetes) (Table 15), the results of an ANOVA have shown statistical significant differences in
mean APACHE II scores only for three groups, all within the CVICU: male patients, patients
aged 40-49, and African American patients. Male CVICU patients with an HAI have a higher
mean APACHE II score (29.20 ± 11.80) than those without an HAI (17.48 ± 7.64), with the
difference being statistically different at p = 0.003. CVICU patients aged 40-49 with an HAI also
have a higher mean score (27.75 ± 11.00) than those without an HAI (15.56 ± 6.04) at p = 0.023
(Table 16). Finally, African American CVICU patients with an HAI possess a greater mean score
of 39.00 than those without an HAI at 18.94 ± 8.65 (p = 0.038). As a result, CVICU patients with
both obesity and smoking habits may be at more risk of contracting an HAI. According to
Karlsson & Beck, (2010), obesity can cause impairment of the immune system which can affect
pulmonary functions making patients more susceptible to infections.
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Table 15
Severity of Illness as Measured by APACHE II by ICU Type, 2010-2014 by Demographics
(Patients with both Obesity and Smoking Habits)
Unit

Mean APACHE Score (SD)
No HAI

Mean APACHE Score (SD)
with HAI

N**

P-value
(ANOVA)

21.20 (7.28)
17.48 (7.64)

21.13 (10.63)
29.20 (11.80)

38
51

0.981
0.003*

23.40 (10.16)
22.50 (9.59)
15.56 (6.04)
17.46 (6.86)
19.09 (7.53)

9.50 (0.71)
27.75 (11.00)
25.33 (10.41)
27.25 (12.18)

5
8
13
16
47

0.119
0.023*
0.122
0.055

19.45 (7.31)
18.94 (8.65)
16.13 (8.43)
17.00 (0.00)

22.43 (12.41)
39.00 (0.00)
21.25 (9.18)
34.00 (0.00)

56
19
12
2

0.363
0.038*
0.357
-

18.50 (6.94)
18.68 (7.72)

20.33 (8.48)
20.33 (7.65)

124
129

0.533
0.537

21.00 (6.59)
20.54 (7.77)
22.22 (7.20)
16.77 (7.13)
18.09 (7.21)

26.50 (6.36)
17.00 (9.56)
20.44 (7.00)

19
13
29
64
128

0.423
0.951
0.346

18.55 (7.39)
18.71 (7.72)
18.45 (6.58)
18.50 (4.95)

19.27 (8.57)
23.67 (4.73)
22.00 (0.00)
-

120
90
41
2

0.761
0.274
0.597
-

18.13 (7.15)
19.00 (7.47)

21.40 (4.39)
14.00 (2.83)

58
58

0.322
0.353

18.33 (8.71)
17.14 (7.99)
16.50 (5.81)
19.89 (7.09)
18.65 (7.61)

12.00 (0.00)
20.00 (3.56)
21.50 (7.78)

6
8
14
32
56

0.569
0.977
0.605

18.65 (7.50)
19.74 (7.61)
16.25 (5.08)
-

20.25 (3.10)
15.00 (0.00)
19.50 (10.61)
-

82
20
14
0

0.674
0.552
0.474
-

CVICU
Gender
Female
Male
Age Group
18-29
30-39
40-49
50-59
≥60
Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other
MSICU
Gender
Female
Male
Age Group
18-29
30-39
40-49
50-59
≥60
Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other
NSICU
Gender
Female
Male
Age Group
18-29
30-39
40-49
50-59
≥60
Ethnicity/Race
Caucasian
African American
Hispanic or Latino
Other

Note. *Statistically significant at p ≤ 0.05.
The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI patients, HAI
patients, or both.
**N represents the Total for both HAI and Non-HAI patients for this specific unit.

91

To summarize, the possible confounders are smoking habits (Table 11, 13, and 15),
obesity (Table 12, 14, and 15), and an interaction of one of the previous two risk factors with
diabetes (Table 13, 14). Diabetes seems to only confound the relationships when patients also
have smoking habits or obesity (Tables 13, 14). Diabetes is one of the largest emerging threats to
health care due to the associated reduced response of T cells, neutrophil function and lack of
humoral immunity which causes increased susceptibility to infections (Casqueiro, Casqueiro &
Alves, 2012). Notably in this study, diabetes by itself has shown to be protective against
contracting an HAI for African American CVICU and MSICU patients aged 50-59 (Table 10).
The implications are that smoking habits and obesity may subject patients to be more at risk of
contracting an HAI (Tables 11-15), while diabetes can produce the same effect only if the patient
also possesses another risk factor (Tables 13-15). Risk factors such as diabetes, obesity and
smoking are predisposing factors which may lead to a decreased host defense (Masud &
Vykoukal, 2011).
Research Question 3 and Hypothesis
RQ#3: What is the association between age, gender, race, ethnicity and HAI status in
three different adult ICUs within an academic medical facility?
H03: There is no association between age, gender, race and ethnicity from the device
associated HAIs identified in the three different adult ICUs within an academic medical facility?
H13: There is an association between age, gender, race and ethnicity from the device
associated HAIs identified in the three different adult ICUs within an academic medical facility?
The data analysis for this research question was comprised of the entire population who
entered into any of the three ICUs during 2010-2014. The total population was looked at to
ascertain population diversity. The data analysis for this research question narrowed down the
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involved specific demographics which were abstracted to determine particular associations in
obtaining an HAI from one of three adult ICUs within an academic medical center. The mean
age for the 319 patients who had HAI status was 59.2 (SD=16.2), while those without an HAI
had a mean age of 58.5 (SD=14.4, n = 3,896). The mean age differences were not statistically
significant p = 0.4508 by t-test. Most patients who acquired infections were in the ≥60 age group
(n=172) (Table 17). Majority of the infections were CAUTI with 204 infections of the 319
infections. More females had CAUTI; however, more males had CLABSI (Table 18). There was
statistical significance found between those with no infections and those with infections within
race and ethnicity in CVICU (X2=18.2, df=3, p<0.001) (Table 16). In MSICU, it was found that
there was a statistical significance between those who acquired an HAI and those who did not in
males and females (X2=14.8, df=1, p<0.001) (Table 16).
The relationships between risk factors and patients contracting an HAI, CVICU patients
who smoke tend to contract an HAI (p = 0.023), with most having CAUTI than other HAIs
(Table 21). Across the ICUs, correlation was statistically significant association between
smoking habits and whether the patient has HAI in the CVICU (p = 0.023), while diabetes was
associated with HAI in the MSICU (p = 0.009), being weakly positive (r = 0.054) and the
correlation is weakly negative at -0.087 and statistically significant at p = 0.003 in the NSICU
(Table 21). Aggregating all the ICUs does not show statistically significant associations (pdiabetes
= 0.594, pobesity = 0.223, psmoking = 0.191) (Table 22).
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Table 16
Demographic and Risk Factors of Patients with No HAI and with HAI in Three Adult ICUs
Demographic
and Risk
Factors
Sex -- n (%)†*
Male
Female
Age -- n (%)
18-29
30-39
40-49
50-59
≥60
Race/Ethnicity
-- n (%)††
African
American
Caucasian
Hispanic or
Latino
Other†
Risk Factors
Obesity
Diabetes
Smoking

CVICU††

MSICU†*

NSICU***

No HAI

HAI

No HAI

HAI

No HAI

HAI

392 (60.9)
252 (39.1)

45 (54.9)
37 (45.1)

1210 (55.0)
990 (45.0)

49 (37.7)
81 (62.3)

499 (47.5)
551 (52.5)

41 (38.3)
66 (61.7)

43 (6.7)
45 (7.0)
77 (12.0)
142 (22.1)
337
(52.43)

0 (0.0)
6 (7.3)
11 (13.4)
14 (17.1)

134 (6.1)
151 (6.9)
234 (10.6)
442 (20.1)

9 (6.9)
6 (4.6)
9 (6.9)
25 (19.2)

67 (6.4)
86 (8.2)
137 (13.1)
253 (24.1)

5 (4.7)
11 (10.3)
19 (17.8)
32 (29.9)

51 (62.2)

1239 (56.3)

81 (62.3)

507 (48.3)

40 (37.4)

182 (28.3)

12 (14.6)

640 (29.1)

36 (27.7)

179 (17.1)

17 (15.9)

365 (56.7)

56 (68.3)

1209 (55.0)

80 (61.5)

763 (72.7)

73 (68.2)

90 (14.0)

9 (11.0)

325 (14.7)

11 (8.5)

102 (9.7)

14 (13.1)

7 (1.1)

5 (6.1)

27 (1.2)

3 (2.3)

6 (0.6)

3 (2.8)

208 (85.6)
180 (85.3)
315 (86.1)

35 (14.4)
31 (14.7)
51 (13.9)

713 (93.2)
553 (92.3)
1029 (94.7)

52 (6.8)
46 (7.7)
58 (5.3)

325 (92.6)
273 (95.1)
530 (90.6)

26 (7.4)
14 (4.9)
55 (9.4)

Note. † Other category included American Indian/Alaska Native, Asian, and Native Hawaiian or Other Pacific
Islander
††
There was statistical significance found between those with no infections and those with infections within race and
ethnicity in CVICU (X 2=18.2, df=3, p<0.001). CVICU HAI vs. No HAI by gender is not statistically significantly
different.
†*
Statistical significance was also found between those with no infections and those with infections within gender in
MSICU (X 2=14.8, df=1, p<0.001). Males had less HAIs than females.
***
NSICU HAI vs. No HAI by gender is not statistically significant.
**Male aggregated total = 2236 (No HAI = 2101; HAI = 135)
**Female aggregated total = 1977 (No HAI = 1793; HAI = 184)
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Table 17
Associations between Age and HAI Type
Age
UNIT
CVICU
X 2 = 8.293
p = 0.217
MSICU†
X 2 = 7.382
p = 0.496
NSICU
X 2 = 7.466
p = 0.487

HAI
Type
CAUTI
CLABSI
VAP
Total
CAUTI
CLABSI
VAP
Total
CAUTI
CLABSI
VAP
Total

18-29

30-39

40-49

50-59

60+

Total

0
0
0

3
2
1
6
3
2
1
6
5
1
5
11

3
7
1
11
7
1
1
9
14
2
3
19

7
4
3
14
12
10
3
25
23
2
7
32

32
11
8
51
59
15
7
81
25
2
13
40

45
24
13
82
87
30
13
130
72
7
28
107

6
2
1
9
5
0
0
5

Note. †Using Stata, Chi-square test shows statistical significance when controlling for sex (MSICU female
patients: p = 0.023). The categorical age distribution across HAI patients is similar to that of the Non-HAI
patients, there is a gradient such that with each increase in age category there was an observed increase in
the proportion of patients within that category. HAIs increase as age increases.

Across the ICUs in Table 17, none of the associations between age and HAI type are
statistically significant: the test for CVICU has a p-value of 0.217 (X 2 = 8.293, n = 82), MSICU
has p = 0.496 (X 2 = 7.382, n = 130), and NSICU has p = 0.487 (X 2 = 7.466, n = 107). Across the
ICUs, older patients (50-59 and 60+) with an HAI outnumbered all other age groups in every
type of HAI except in the CVICU for patients with CLABSI, in which the number of those aged
40-49 (7) were greater than the number of those aged 50-59 (4). Notably for MSICU patients,
controlling for sex results were statistically significant (MSICU female patients: p = 0.023),
indicating that older female patients may be more likely to contract an HAI, especially a CAUTI,
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than other patients. As such, the sex of the patient may matter more as a confounding factor than
the age group.
Table 18
Associations between Sex and HAI Type
Sex
UNIT

HAI Type

CVICU

CLABSI

21

3

24

X = 19.831

CAUTI

15

30

45

p <0.001*

VAP

9

4

13

Total

45

37

82

MSICU

CLABSI

18

12

30

X 2 = 8.618

CAUTI

26

61

87

p = 0.013*

VAP

5

8

13

Total

49

81

130

CLABSI

3

4

7

X = 2.435

CAUTI

24

48

72

p = 0.296

VAP

14

14

28

Total

41

66

107

2

NSICU
2

Male

Female

Total

Comparing the ICUs in Table 18, CVICU and MSICU have shown statistical significance
(pCVICU <0.0001 and pMSICU = 0.013), while NSICU has not (pNSICU = 0.296). In the CVICU,
male patients outnumber female patients for CLABSI 7:1, female patients outnumber male
patients 2:1 for CAUTI, and male patients again outnumber female patients for VAP 9:4.
Overall, nearly 55% of patients with an HAI were male in the CVICU, with the statistical
significance suggesting that male patients in the CVICU were more likely to contract an HAI. In
the MSICU, female patients outnumber male patients for every HAI type except CLABSI: male
patients outnumber female patients 3:2 for CLABSI, while female patients outnumber male
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patients 61:26 for CAUTI and 8:5 for VAP. Approximately 58% of patients with any type of
HAI were female, with the statistical significance implying that female patients in the MSICU
were more likely to get an HAI. In the NSICU, female patients again outnumber male patients
for all HAI types except VAP, which they tie: female patients outnumber male patients 4:3 for
CLABSI and 2:1 in CAUTI, while the number of patients with VAP was the same for both sexes
(i.e. 1:1). Statistical insignificance suggests that neither sex were more likely to contract an HAI.
Table 19
Associations between Ethnicity/Race and HAI Type

UNIT

HAI Type

CVICU†
X2=
9.876
p = 0.130

CLABSI

17

CAUTI

29

2

VAP

10

Total
MSICU
X2=
7.624
p = 0.267

Other

Total

1

24

10

4

45

2

1

0

13

56

9

12

5

82

CLABSI

21

3

6

0

30

CAUTI

50

6

29

2

87

VAP

9

2

1

1

13

Total

80

11

36

3

130

3

1

3

0

7

48

10

12

2

72

22

3

2

1

28

73

14

17

3

107

NSICU†† CLABSI
X2=
CAUTI
6.124
p = 0.409 VAP
Total

Caucasian

Ethnicity/Race
African
Hispanic/Latino
American
5
1

Note. † Chi-square test shows statistically significance when controlling for age and gender (female CVICU
patients aged 50-59: p = 0.017; female CVICU patients aged 60+: p = 0.019).
†† Chi-square test shows statistically significance when controlling for age and gender (female NSICU patients aged
50-59: p = 0.021).
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Across the ICUs in Table 19, none of the associations between ethnicity/race and HAI
type are statistically significant: the test for CVICU has a p-value of 0.130 (X 2 = 9.876, sample
size = 82), MSICU has p = 0.267 (X 2 = 7.624, sample size = 130), and NSICU has p = 0.409 (X 2
= 6.124, sample size = 107). However, when controlling for age and gender, female CVICU
aged 50-59 (p = 0.017) and aged 60+ (p = 0.019) were statistically significant across the ethnic
groups in relation to HAI types. Similarly, female NSICU patients aged 50-59 were found to be
statistically significant (p = 0.021). In the CVICU, nearly 70% of patients with an HAI were
Caucasian, while approximately 15% of patients with an HAI were African American—the
remaining patient populations were Hispanic/Latino and other groups. For each HAI type, the
number of Caucasians was greater than the number of the African Americans, Hispanic/Latinos,
and other ethnicities/races. In the MSICU, the percentages were similar: over 60% of patients
with an HAI were Caucasian, while almost 30% were African American and 10% were
Hispanic/Latino and other ethnic groups. In the NSICU, close to 70% of patients with HAI were
Caucasian, 16% were African American, and the rest were Hispanic/Latino and other
ethnicities/races. Thus, race may not have a strict association with a type of HAI, but it may be
confounded by age and gender.
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Table 20
Associations between Risk Factors and HAI Types
Risk Factors

UNIT

HAI Type

Diabetes
N
Y

Obesity
N
Y

Smoking†
N
Y

CVICU

CLABSI

17

7

14

10

14

10

CAUTI

27

18

25

20

16

29

VAP

7

6

8

5

1

2

MSICU

2

X = 1.239

X = 0.162

p = 0.538

p = 0.922

X = 9.412
p = 0.009*

CLABSI

19

11

14

16

14

16

CAUTI

56

31

57

30

51

36

VAP

9

4

7

6

7

2

X = 0.145

2

6
2

X = 3.531

X = 1.304

p = 0.171

p = 0.521

p = 0.930
NSICU

12
2

CLABSI

6

1

6

1

3

4

CAUTI

62

10

53

19

37

35

VAP

25

3

22

6

12

16

X 2 = 0.188
p = 0.910

X 2 = 0.678

X 2 = 0.686

p = 0.713

p = 0.710

Note. * Statistically significant at p ≤ 0.05
†Smoking is not statistically significant when controlling for age for each ICU. Chi-square test shows results to be
statistically significant when controlling for gender (CVICU Males: p = 0.032) or ethnicity (CVICU Caucasians: p =
0.042), but not for both simultaneously.

All through the ICUs in Table 20, CVICU patients who smoke tend to contract an HAI (p
= 0.009), with most having CAUTI than other HAIs. The association is not significant for
patients who smoke when controlling for age for each ICU; however, when controlling for either
sex or ethnicity but not both simultaneously, the p-values are statistically significant (CVICU
males: p = 0.032 vs. CVICU Caucasians: p = 0.042). Changes in statistical significance with
respect to different combinations of demographic variables imply that sex and ethnicity/race are
confounding factors in those with smoking habits who contract an HAI in the CVICU. Thus, sex
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and ethnicity/race behave as catalyst variables for those who smoke and contract an HAI. Across
the ICUs in Table 21, association was statistically significant association between smoking
habits and whether the patient has HAI in the CVICU (p = 0.024). Diabetes was associated with
HAI in the MSICU (p = 0.009), being weakly positive (r = 0.054). For NSICU, the correlation is
weakly negative at -0.087 and statistically significant at p = 0.003. In Table 22, the distribution
between any HAI type and whether a patient possesses a risk factor on an aggregated basis is
statistically similar (pdiabetes = 0.594, pobesity = 0.223, and psmoking = 0.191), indicating that the ICUspecific level of analysis reveals more significant associations than aggregation (Table 22).
Table 21
Risk Factors of Patients Admitted to Each ICU

UNIT

CVICU

HAI

Diabetes**
Y

N

Y

N

Y

NO

464

180

436

208

329

315

YES

51

31
X =3.426,
p=0.064
1647
553

47

chi-square
NO
YES

84

35
X =3.523,
p=0.061
1487
713
2

NO

52
X =3.207,
p=0.073
725
325

72
58
2
X =0.230,
p=0.632
520
530

YES

93

81

52
55
2
X =0.033**,
p=0.855

chi-square

14
X =8.685,
p=0.003*
2

chi-square

78

31
51
2
X =5.133,
p=0.023*
1172
1029

46
X =6.750,
p=0.009*
777
273
2

NSICU**

Smoking

N

2

MSICU**

Obesity

2

26
X =2.034,
p=0.154
2

Note. *Smoking was correlated with acquiring a device-associated infection in CVICU (r = 0.085, p = 0.023).
**In MSICU, Pearson correlation between HAI and diabetes is weakly positive at 0.054, but statistically significant
(p = 0.009). Thus, MSICU patients with diabetes have a weak association with acquiring a type of HAI. For
NSICU, the correlation is weakly negative at -0.087, being statistically significant (p = 0.003).
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Table 22
Risk-Factors of Patients with Device-Associated Infections and Patients with No Infections
Diabetes

Obesity

Smoking

HAI
N

Y

N

Y

N

Y

CLABSI

42

19

34

27

31

30

CAUTI

145

59

135

69

104

100

VAP

41

13

37

17

20

34

1006

2648

1246

2020

No Infection

2888
2

Chi-square

X =1.900,
p=0.594

2

X =4.387,
p=0.223

1874

2

X =4.749,
p=0.191

Note. No statistically significant correlation found between comorbidities and device-associated infections.

Research Question 4 and Hypothesis
RQ#4: Are there significant differences in the types of microorganisms (e.g. genus,
species, and susceptibility according to the Clinical and Laboratory Standards Institute (Patel et
al., 2015) which are associated with device-related HAIs in three adult ICUs within an academic
medical facility?
H04: There are no significant differences in the types of microorganisms (e.g. genus,
species, and susceptibility according to the Clinical and Laboratory Standards Institute (Patel et
al., 2015) associated with device-related HAIs in three adult ICUs within an academic medical
facility.
H14: There are significant differences in the types of microorganisms (e.g. genus, species
susceptibility according to the Clinical and Laboratory Standards Institute (Patel et al., 2015)
which are associated with device-related HAIs in three adult ICUs within an academic medical
facility.
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It was found from Chi-square analysis that the pattern of microbes was dissimilar for the
three HAIs considered, 83% of yeast infections were associated with CAUTI (X2=56.759,
p<0.001) (Table 23). Additionally, microorganism was significantly associated with ICU
location (X2=28.536, p<0.001) (Table 24). The microorganisms contributing to CLABSI and
CAUTI are listed in Tables 26 and 27, respectively. It was found that the majority of the
CLABSIs were caused by gram-positive bacteria, while CAUTIs were predominantly gramnegative bacteria, and the majority of VAPs identified were clinically defined without bacterial
infections (see Appendix B for Pneumonia Flow Diagram).
The number of multidrug resistant microorganisms identified in all three ICUs was thirty
seven or 13% of the organisms identified (Figure 7). The distribution of yeast was significantly
lower in both males and females in NSICU. The distribution of the microorganisms was
statistically dissimilar with female patients in the three ICUs (X2 = 25.653, p < 0.001), while the
distribution with respect to males was similar (X2 = 6.159, p = 0.188) (Table 25).
Table 23
Distribution of Microorganisms and Device-Associated Infections
Microorganism2

Device-Associated Infection
Total
CAUTI

CLABSI

VAP

Gram positive cocci

21

31

8

60

Gram negative rods

125

18

18

161

Yeast

58

12

0

70

Total

204

61

26

2911

Note. 1Some Ventilator Associated Pneumonias are clinically defined
2
Microorganism was found to be associated with device-associated infections (X2=56.759, p<0.001)
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Table 24
Distribution of Device-Related Bacterial Infections Across the Three Adult ICUs
ICU
Microorganism2

Total
CVICU

MSICU

NSICU

Gram positive cocci

17

25

18

60

Gram negative rods

32

58

71

161

Yeast

24

40

6

70

Total

73

123

95

2911

Note. 1Total excludes clinically defined Ventilator Associated Pneumonias (VAPs)
2
Microorganism was found to be associated with type of intensive care units (X2=28.536, p<0.001)

Table 25
ICU-specific Gender Breakdown of Various Microbes
ICU Type
Gender

Microorganism

CVICU

MSICU

NSICU

Female†

GPC

4

14

9

GNR

16

35

46

YST

14

28

2

GPC

13

11

9

GNR

16

23

25

YST

10

12

4

Male

Note. † Microorganism was significant in females between the three ICUs (X2=25.653, p < 0.001) but not for males
(X2 = 6.159, p = 0.188). For Males & Females when considered together: (X2 = 28.536, p < 0.001).
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Table 26
Microorganisms Contributing to CLABSI
CLABSI Organisms

Gram-negative rods

Gram-positive cocci

Yeast
Total

Acinetobacter baumanni
Escherichia coli
Enterobacter cloacae
Klebsiella pneumonia
Pseudomonas aeruginosa
Serratia marcescens
Stenotrophomonas maltophilia
Enterococcus faecalis
Enterococcus faecium
Methicillin-resistant Staphylococcus aureus
Staphylococcus aureus
Staphylococcus epidermidis
Vancomycin-resistant Enterococcus
Streptococcus milleri
Candida species

2
4
1
4
4
1
2
7
1
1
1
7
13
1
12
61

Table 27
Microorganisms Contributing to CAUTI
CAUTI Organisms

Gram-negative rods

Gram-positive cocci
Yeast
Total

Citrobacter amalonaticus
Escherichia coli
Enterobacter aerogenes
Enterobacter cloacae
Klebsiella pneumonia
Morganella morganii
Proteus mirabilis
Pseudomonas aeruginosa
Stenotrophonas maltophilia
Enterococcus faecalis
Vancomycin-resistant Enterococcus

1
62
3
2
25
2
4
25
1
15
6
58
204
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Comparison of MDRO Within HAI Types
2010-2014
250
MDRO

(4.4%)

# OF ORGANISMS

200

Susceptible
Organisms

9

150

100

195

(32.8%)
20

50

(30.8%)
8

41

18

0
CAUTI

CLABSI

VAP

TYPE OF HAI

Figure 7. Multidrug resistant organisms compared to susceptible organisms.
See Appendix F for additional MDRO information.
Summary
Chapter 4 provided the results overview of analyzed data for this research study.
Majority of patients in the study from 2010-2014 were admitted to the MSICU (55.3%),
Caucasians (60.4%), males (53.1%), and 60 years or older (53.6%) (Table 3). Those who
acquired device-associated infections while hospitalized were primarily Caucasians (65.5%),
females (57.7%), 60 years or older (53.9%), and were in MSICU (40.8%) (Table 3). The
majority of the device-associated infections within the 5-year study period in the academic
medical center were CAUTI (63.9%). It was found that there was no statistically significant
difference in incidence rates of any device-related nosocomial infections between the three ICUs
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between 2010 and 2014 (Table 4). There was no significant statistical difference in CLABSI and
VAP SIR of device-related nosocomial infections between the three ICUs (Table 5). However,
there was a statistically significant difference in CAUTI SIR (p = 0.027) (Table 5). The
difference was found in NSICU (Table 5). The study also analyzed the association between
utilization of devices and infections rates, and no significant correlation was found (Table 6).
Furthermore, there was no significant difference found in mean severity of illness scores
(measured by the APACHE II) across the ICUs (Table 7). However, there was a significant
difference in mean severity of illness scores of patients within the three ICUs, specifically in
NSICU (Table 7). Significant difference of APACHE II scores was based on Bonferroni posthoc analysis in NSICU (p < 0.001) (Table 8). After analyzing risk associations (Tables 11-15),
the difference in the mean APACHE II scores, between those who acquired an HAI and those
patients who did not acquire an HAI among several demographic groups has revealed the
possible confounders to be smoking habits (Table 11, 13 and 15), obesity (Table 12, 14, and 15),
and an interaction of one of the previous two risk factors with diabetes (Table 13, 14) between
those with and without an HAI. Correlation was statistically significant between diabetes and
acquiring a device-associated infection in MSICU (r = 0.054, p = 0.009) and NSICU (r = -0.087,
p = 0.003) (Table 21). Smoking was correlated with acquiring a device-associated infection in
CVICU (r = 0.085, p = 0.023) (Table 21). In MSICU, Pearson correlation between HAI and
diabetes is weakly positive at 0.054, but statistically significant (0.009) (Table 21). Thus,
MSICU patients with diabetes have a weak association with acquiring a type of HAI. For
NSICU, the correlation is weakly negative at -0.087, being statistically significant (0.003).
Chi-square analysis found some significant differences between demographic
characteristics and types of infections, as well as between types of organisms and types of
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infections. The significant and non-significant findings of this research will be discussed in
Chapter 5 and will include recommendations for future research and implications for social
changes concerning healthcare.
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Chapter 5: Discussion
Introduction
The purpose of the this study was to evaluate the characteristics and trends of deviceassociated nosocomial infections (CLABSI, CAUTI, VAP) from 2010-2014 in three ICUs of a
major teaching medical center. Guidelines from the NHSN served as the definitions for inclusion
criteria for the study for device-associated infections. The research study was a quantitative
analysis of secondary data abstracted from the electronic medical records of an academic
medical facility in the state of Texas.
Selected medical records of patients admitted to the three ICUs (cardiovascular, medicalsurgical, and neurosurgical) within two hospitals of an academic medical facility between 2010
and 2014 were obtained from their department of informatics. Cases were defined as patients
who developed a device-associated infection from either a central line, Foley catheter, or a
ventilator while hospitalized greater than 2 calendar days. The majority of patients were
Caucasian and older than 60 years of age; I found that female patients comprised 57.7% of all
patients with an HAI (p < 0.001, Table 3). Differences in CLABSI, CAUTI, and VAP incidence
rates within 5 years were not statistically significant across the ICUs (Table 4). The mean
CAUTI SIR was different in NSICU within the 5-year study period compared to other ICUs (p=
0.027; Table 5). SIRs for other device-associated infections were not statistically significant
(Table 5). Furthermore, device utilization rates were not found to be correlated with specific
device infection rates. The mean severity of illness scores was significantly lower in the NSICU
patients who developed a device-associated infection (Table 7). The mean severity of illness
scores may be attributed to the fact that the NSICU patient population is primarily admitted with
neuropathophysiology issues without concurrent renal, liver, or cardiopulmonary comorbidities.
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Interpretation of Findings
Research Question 1
In Research Question 1, I examined differences in incidence rates associated with ICU
device-related nosocomial infections. I found that MSICU had the highest CAUTI rate with a
mean of 3.98 for the entire 5-year period between the three ICUs. CVICU had the highest
incidence rate for CLABSI with a mean of 1.16 and a standardization infection ratio of 1.4
compared to the other two ICUs. The highest incidence rate for ventilator associated pneumonias
was in the neurosurgical ICU with a mean of 4.67 (Table 4). I found that CVICU had the highest
rate for use of ventilators and central lines (Figure 6). The highest usage of Foley catheters was
observed in the neurosurgical ICU (Figure 3). The utilization findings were not correlated to
infection rates (Table 6). However, with VAP cases, the neurosurgical ICU had a high rate
during 2010 through 2012 and then leveled off the following 2 years (Figure 6). In findings for
the three ICUs, I identified CVICU as having the lowest CAUTI rate (Figure 3). The
neurosurgical ICU had the lowest CLABSI rate, which could be attributed to the lower rate of
utilization of central lines (Figure 2). The findings revealed that neurosurgical ICU had the
highest VAP rate (4.6; Figure 5) and standardized infection ratio (2.24; Table 5) while utilizing
the lowest number of ventilator days as compared to the other two ICUs (Table 6). However, in
this study, the neurosurgical ICU had a lower rate of CAUTI and CLABSI (CAUTI 3.9;
CLABSI 0.6) as compared to the national pooled mean of other academic medical centers
(CAUTI 5.3; CLABSI 0.9; See Figure 6, Appendix E; Dudeck et al., 2015). There was a
significant difference in mean CAUTI SIR by unit location (p=0.027; Table 5). The significant
difference based on Bonferroni post-hoc analysis within unit (p=0.046) for neurosurgical ICU
(NSICU; Table 5). The ANOVA results revealed a statistically insignificant difference between
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the CLABSI, CAUTI, and VAP rates between the three ICUs (Table 4: pCLABSI = 0.349, pCAUTI =
0.187, pVAP = 0.052).
Research Question 2
In Research Question 2, I studied the association between the severity of illness
(APACHE score) and CLABSI, CAUTI, and VAP for each of the three ICUs in an academic
medical facility. The APACHE score is a severity of disease classification system that only looks
at the first 24 hours after being admitted into the ICU. In this study, the difference in mean
APACHE scores between the three types of device-associated infections was not statistically
significant when aggregated (p=0.331; Table 8). When disaggregating by ICU, there were
statistically significant differences (pCAUTI < 0.001, pCLABSI = 0.048, pVAP < 0.001), showing that
aggregation has masked significant associations (Table 8). The Bonferroni post-hoc analysis
was used to help compare the groups and recognize differences between the groups. I found that
patients admitted to NSICU who acquired a device-associated infection had a statistically lower
mean APACHE II score based on Bonferroni post-hoc analysis (p <0.001) compared to those
who were admitted to CVICU and MSICU (Table 7). In analyzing the ICUs individually, I found
statistical significant differences in mean APACHE II scores between the specific ICU and
patients contracting an HAI. For any type of HAI, there was a statistically significant difference
in mean APACHE II scores (pCVICU = 0.004, pMSICU < 0.001, pNSICU < 0.001; Table 7).
Additionally, there were statistically significant differences in mean APACHE II scores between
the units for all three HAI types (pCAUTI < 0.001, pCLABSI = 0.048, pVAP < 0.001; Table 8).
I determined that patients in the three ICUs who had the highest APACHE score were
more vulnerable in acquiring a VAP as compared to those who acquired a CAUTI and/or a
CLABSI. When controlling for age and gender differences, the mean scores were statistically
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significant when comparing between APACHE II scores and ICU units (p < 0.001).
Comparisons of the three types of device associated infections with severity of illness (p = 0.331)
illustrated no significant differences when controlling for age and gender (p = 0.262; Table 8).
Comparing the APACHE II means over several demographic groups by ICU with respect
to different combinations of risk factors as shown in Tables 9 through Table 15 has revealed the
possible confounders to be smoking habits (Table 11, 13, and 15), obesity (Table 12, 14, and 15),
and an interaction of one of the previous two risk factors with diabetes (Table 13, 14) between
those with and without an HAI. Smoking habits by itself may confound the relations between
demographic groups and contracting an HAI (Table 11), as well as its interaction with the other
risk factors (i.e., smoking habits and diabetes or obesity; Table 13 and 15). Diabetes seems to
only confound the relationships when patients also have either smoking habits or obesity.
Notably, diabetes by itself has shown to be protective against contracting an HAI for African
American CVICU and MSICU patients aged 50-59 (Table 10).
Research Question 3
The third research question involved the association between age, gender, race, and
ethnicity with regard to acquiring a HAI in three different adult ICUs within an academic
medical facility. I found that most of the device-related nosocomial infections were attributed to
patients who were over 60 years of age. The majority of the patient population was Caucasian for
all three ICUs (Table 3), which did not aid in the determination of race and ethnicity being a
factor for acquiring a device-associated infection. Chen et al. (2009) found that the most
common nosocomial infection was CAUTI, and it was predominantly in the medical surgical
ICU. Other scholars have shown that the most common nosocomial infections in ICUs were
respiratory tract infections which were linked to mechanical ventilator pneumonias (Rosenthal et
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al., 2012). In this study, I found that the most common infection was CAUTI followed by
bloodstream infections, which were also identified in this study (Figure 5). The female gender
had a higher occurrence for CAUTI, while the male gender represented the majority of the
CLABSIs identified for all three ICUs (Table 18). Furthermore, I found MSICU as having the
highest rate for CAUTI (4.1 per 1000 urinary catheter days), while CVICU had the highest rate
of CLABSI (1.1 per 1000 central line days), and neurosurgical ICU had the highest rate for VAP
(4.6 per 1000 mechanical ventilator days) (Figure 5).
For the chi-squared tests involving the associations of demographic traits and risk factors
across the ICUs for each HAI type, there is a statistically significant association with an HAI and
age for female MSICU patients (p = 0.023, Table 17); otherwise, no statistically significant
association was found between age and HAI type. As such, the gender of the patient may matter
more as a confounding factor than the age group. Across the ICUs, none of the associations
between ethnicity/race and HAI type are statistically significant at the ICU specific level: the test
for CVICU has a p-value of 0.130 (X 2 = 9.876, n = 82), MSICU has p = 0.267 (X 2 = 7.624, n =
130), and NSICU has p = 0.409 (X 2 = 6.124, n = 107; Table 19). Statistical insignificance
remains even when controlling for age and sex. Thus, race may not be a confounding variable.
Finally, for risk factors, CVICU patients who smoke tend to contract an HAI (p = 0.009), with
most having CAUTI than the others (Table 20). The association is not significant for patients
who smoke when controlling for age; however, when controlling for either sex or ethnicity but
not both simultaneously, the p-values are statistically significant (CVICU males: p = 0.032 vs.
CVICU Caucasians: p = 0.042; Table 20). Changes in statistical significance with respect to
different combinations of demographic variables implies that sex and ethnicity/race are
confounding factors in those with smoking habits and contract an HAI in the CVICU. Thus, sex
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and ethnicity/race behave as an initiator for those who smoke and contract an HAI. Furthermore,
Pearson correlations show statistically significance between diabetes and acquiring a deviceassociated infection in MSICU and a negative correlation in NSICU (Appendix D). In MSICU,
Pearson correlations between HAI and diabetes are weakly positive at 0.054, but statistically
significant (0.009; Appendix D). Thus, diabetic patients in MSICU have a weak association with
acquiring a device associated healthcare infection. As for the patients in NSICU who were
statistically significant with a p-value of 0.003, had a Pearson correlations that was weakly
negative at -0.087. Thus, NSICU patients with diabetes have a weak association with not
acquiring an HAI infection.
Research Question 4
The last research question examined the differences in the types of microorganisms and
susceptibilities which were associated with device-related HAIs in the three adult ICUs within
the academic medical facility. The data analysis discovered that the majority of the HAIs were
caused by gram negative rods (Table 23-24). The gram negative rods were associated with the
majority of the CAUTI and VAP infections. Doshi et al. (2009) demonstrated comparable
findings of gram negative rods associated with the majority of CAUTIs. In this study, the
majority of CAUTIs were attributed to gram negative bacteria with the majority being identified
as E. coli (Table 27). The gram negative bacteria were further grouped as 99 cases caused by
bacteria from the Enterobacteriaceae family. The non-fermenting gram negative rods accounted
for only 26 of the CAUTI cases with Pseudomonas aeruginosa being the majority of the cases.
There were 58 cases of yeast and 21 cases of gram positive bacteria causing CAUTI. However,
for the CLABSI cases, the major cause of infection was caused by gram positive cocci. The
CLABSI organism distribution consisted of 31 gram positive bacteria, 18 gram negative bacteria
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and 12 yeast. The CLABSI cases had the majority of multidrug resistant organisms (MDRO’s)
with 20 identified as cause of infection. The most common MDRO identified was vancomycin
resistant enterococcus (VRE) which were found to be the cause of 13 cases of CLABSI and 6
cases of CAUTI. There were only 12.7% of MDRO’s identified for all three device-related
infections within the three adult ICUs. There were a total of 161 gram negative bacteria
contributing to the device-related infections in the ICUs. NSICU had the highest number of gram
negative rods with a total of 71 followed by MSICU and then CVICU (Table 24). The second
group of organisms contributing to the HAIs were yeast in which there was a total of 70
infections associated with the three types of intensive care units. The results found that of the
total HAIs in MSICU, 40 cases were attributed to yeast (Table 24). The yeast were found causing
infections in patients who had Foley catheters followed by patients who had placement of central
lines. Gram positive cocci contributed to the majority (51%) of central line-associated
bloodstream infections. Of all the MDRO’s identified, 51.4% were vancomycin resistant
enterococcus (VRE). VRE was the most commonly identified pathogen causing deviceassociated HAIs at this academic medical center (Tables 26-27, Figure 7). The results from this
study are different from what was identified in the literature. On the contrary, literature review
has identified MRSA more often as the common pathogen causing healthcare associated
infections (Doshi et al., 2009). In this study, there were only 5 MRSA infections contributing to
13.5% of the MDRO cases. The MRSA infections were attributed to one CLABSI and four VAP
cases.
VRE was found to cause 21% of CLABSIs and only 2.9% of CAUTIs.
Microbiologically speaking, one would think that VRE as an enteric bacteria would demonstrate
higher device associated CAUTIs. This would be due to the proximity of the urethral indwelling
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catheter to the enteric flora of the perirectal area. In this study, central lines were associated with
a higher number of VRE device associated infections. These findings are in contrast to MRSA
being identified in other studies as common pathogens causing HAIs. Staph species, Staph
aureus, Enterococcus species and Candida species have been found in literature to be the most
prevalent bacteria with central line and other device associated infections (O’Grady et. al., 2011).
According to O’Grady et al. (2011), MRSA was the most common reported bacteria causing
device associated infections and accounts for more than 50% of the Staphylococcus aureus
isolates identified in the ICUs. MRSA was demonstrated to cause 8.5% of the HAIs reported to
the National Healthcare Safety Network during the period of 2009-2010 (Sievert et al., 2013).
According to the literature review, VRE is associated with increased ICU cost, hospital mortality
and length of stay. There is a high risk of acquisition of VRE from the hospital environment
which could contribute to device associated HAIs (Sydnor & Perl, 2011). This information may
be useful for future research and may provide additional information regarding the relationship
of VRE with device associated infections. Other findings in this study, revealed that the
microorganisms isolated from ICU patients were statistically significant in females between the
three ICUs (X 2=25.653, p<0.001) but not for the male gender (X2 = 6.159, p = 0.188; Table 25).
Lower socioeconomic status has been linked to poor health outcomes due to lack of
access to health care services (Saydah, Imperatore, & Beckles, 2013). Therefore, once admitted
to an acute care setting, the poor health conditions make these patients more susceptible to
acquiring HAIs. In the broader picture, improving socioeconomic status for all demographics
could help in reducing the likelihood of acquiring healthcare associated infections. The
significance of this study was to examine the findings in order to understand the incidence rates
and SIR associated with each ICU (Tables 4-6). The findings should be able to provide
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information that was necessary in continuously improving patient safety and patient outcomes.
This study allows the opportunities for exploration of some components of the eco-social theory
and how each factor affects acquiring a healthcare associated infection. This can place emphasis
on the patterns of HAIs which may develop within a set population (Krieger, 2001). The model
provided a context of health analysis and could help to determine the overall understanding of
health outcomes.
Limitations of the Study
This research study used three different intensive care units within an academic medical
center in the state of Texas. It was assumed that patients in the three ICUs had unique clinical
dispositions requiring them to be admitted to the different ICU locations (cardiovascular,
medical-surgical, and neuro) with varying clinical services and characteristics. The findings from
this study may not be generalizable to other academic medical facilities causing potential bias as
well. The other limitations to consider involve predisposed patients that can develop particular
illnesses and infections which can cause a high occurrence of devices associated infections. The
varying types of ICUs may affect the types of infections and organisms revealed. Since the ICUs
were different in characteristics for services provided based on clinical needs of patients (neuro,
cardiovascular, medical-surgical), it was assumed that patients received unique clinical care
based on individual unit, thus affecting infection rates. Because the patient populations are
subject to multiple characteristics, such as differences in demographics and severity of illness,
the nature of the patients confound interpretations of the results. Comparing the patient
populations has revealed that while they were similar for most traits of the patient, comparing the
sex of the patient with respect to the HAI type (i.e., analyzing male patients subject to the
different types of HAI across the ICUs and then comparing those results to female patients
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subject to the same characteristics) has revealed statistically significant differences (Table 3),
notably for patients with smoking habits (Table 11). Similar differences in statistical significance
were found for several ethnic/racial group constant when determining the subgroup of patients
who smoke and acquire a type of HAI (Table 11). Although an attempt to control the
confounding factors was made, a limitation of this approach in this study is that the lifestyles of
the patients, such as specific dieting habits, are not recorded in the clinical data. The potential
impact on the results may cause differences in the statistical significance in the chi-squared tests
and thus possible estimation bias in the p-values.
External factors such as different types of device brands and supplies used between the
three ICUs, variables in collection of culture samples, and variances in insertion of devices and
daily care by staff may contribute to an increased risk for developing a device associated HAI.
Other limitations include definition changes which have led to fewer identified HAIs. For
example, the NHSN CAUTI definitions for 2015 have excluded all yeast from the CAUTI
criteria, whereas prior to 2015, yeast would have been considered a pathogen contributing to a
CAUTI. Future findings may show lower number of CAUTIs since Candida species have been
found to be genitourinary tract colonizing organisms but are now excluded from the definition
criteria. Female gender and indwelling urethral catheters are known risk factors for candiduria.
Incorporation of the exclusion criteria may cause under representation of female gender urinary
tract infections caused by Candida. (Pallet & Hand, 2010).
Recommendations for Future Research
Additional studies may include device utilization ratios in order to focus on excess use of
device usage for each intensive care unit in an academic medical center. Since this study was
unable to capture length of stay for all patients, further data analysis regarding morbidity and
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mortality can be examined along with the length of stay can be reviewed in comparing each
intensive care unit respectively. There could be more investigation focused on demographics and
length of stay to include patients who were admitted to the intensive care units and did have a
device in place while in the ICU but who did not develop a healthcare associated infection within
this academic medical facility. Future research could look specifically at the neurosurgical ICU
to investigate the high rate of VAP and the factors which could be involved in contributing to
this infection rate. The correlation between the microorganisms identified and device associated
infection type needs to be further investigated as to mode of transmission, portal of entry and
each susceptible host. Due to limited data, researcher was unable to conduct a case control study,
however, future study could possibly be a case control study which will examine all patients with
central lines, Foley catheters and ventilators within each specific ICU in an academic medical
facility.
Implications for Social Change
Patients who are admitted into an intensive care unit of a hospital are likely to have an
increased occurrence of device associated HAIs. Literature review has shown that during
hospitalization, every patient who was admitted into an ICU and has a device such as a central
line, Foley catheter or a ventilator placement has a higher chance of developing a device
associated infection (Magil et al., 2014). The impact of these infections on patient outcomes are
associated with increased length of stay, excess hospital cost, and an increased chance of
morbidity. In this study, the researcher was unable to gather all the length of stay data for each
patient and therefore was not able to evaluate LOS. In the United States, the estimated medical
costs of HAIs are nearly $45 billion each year (Krein et al., 2012). It is estimated that over 1.7
million HAIs occur in patients who have been admitted into a hospital setting each year (Magill
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et al., 2014). Literature review has shown that HAIs have resulted in 99,000 deaths in 2002,
which places HAIs in the top ten causes of death in the United States depending on the risk
factors and other disease factors the patient may already have present (Krein, et al., 2012). The
social change implications from this research could aid in the understanding of the incidence
associated with each device associated infection and the relationship attributed to each intensive
care unit. Social change supports the need for guiding infection prevention and control for all
three intensive care units to reduce the infection rates and produce healthier outcomes for
patients and the community. Understanding the types of infections associated with each intensive
care unit and the microorganisms attributing to the infections may provide further information
providing interventions and best practice guidelines. A better understanding of knowledge for
prevention and control of nosocomial infections could provide practice recommendations which
may assist in the development of more effective guidelines. These types of changes and
improvements could be used to process social attitudes in nursing care, antibiotic usage,
behaviors, decision making, hand hygiene, maintenance and care of devices, and other important
factors which could contribute to infection prevention.
Conclusion
Device associated HAIs are a threat to patient safety particularly those patients who are
admitted into an intensive care unit. Additional attention should be given to each ICU relating to
the types of organisms identified, and each type of device associated infection. The majority of
gram positive bacteria identified in this study as the cause of CLABSI should be examined for
proper skin preparation along with care bundles. According to Doshi (2009), over half of the
CLABSIs identified are preventable with implementation evidence based practices for central
line insertion and maintenance of lines. Skin flora such as gram positive bacteria are inclined to
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be heavily present on the skin therefore potentially contributing to CLABSIs (Doshi et al., 2009).
The link between CAUTIs and gram negative bacteria should be examined further. There should
be standardized evidence based practices followed for all the ICUs. Surveillance monitoring
with educational sessions should be considered to help provide better opportunity to make the
necessary changes in healthcare practices for device insertion and maintenance. The ultimate
goal should be to achieve a reduction in device-associated HAIs. There needs to be additional
research to determine best practice for Foley and central line care. Additional studies and further
findings should be performed on VRE isolates to determine infection patterns for this gram
positive multidrug resistant organism since the study showed the increase number of VRE cases
with these device-related ICU patient infections. This information could be helpful by targeting
the organisms identified with each type of device associated infection as well as the types of
devices identified with each ICU. A multifaceted approach can be beneficial to dissect the causes
and commonalities with each infection. Further studies may be necessary to gather additional
information as to implement risk reduction measures.
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Appendix A: Types of Device-related Healthcare Associated Infections
Catheter Associated Urinary Tract Infections
The SUTI criterion for 1a, as defined by the (Horan, Andrus, & Dudeck, 2008), include
all of the following elements which must occur within a timeframe that does not exceed a gap of
one calendar day between any two elements:
1) The patient had an indwelling urinary catheter in place for >2 calendar days and the catheter
was in place on the day when all elements of the criterion were first present together
2) And patient displays at least one of the following signs or symptoms, with no other recognized
cause(s): fever >38°C; suprapubic tenderness; costovertebral angle pain or tenderness.
3) And a positive urine culture of ≥105 colony-forming units/ml with no more than two species of
microorganisms.
OR
1) The patient had an indwelling urinary catheter in place for >2 days and had it removed <48
hours before all elements of the criterion were first present together.
2) And at least one of the following signs or symptoms, with no other recognized cause(s): fever
>38°C; urgency; frequency; dysuria; suprapubic tenderness; costovertebral angle pain or
tenderness.
3) And a positive urine culture of ≥105 colony-forming units/ml with no more than two species of
microorganisms.
The SUTI criterion for 2a include all of the following elements which must occur within
a timeframe that does not exceed a gap of one calendar day between any two elements:
1) The patient had an indwelling urinary catheter in place for >2 calendar days and the catheter
was in place on the day when all elements of the criterion were first present together.
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2) And a positive urinalysis with at least one of the following: a positive dipstick for leukocyte
esterase and/or nitrite; pyuria; microorganisms seen on Gram’s stain of unspun urine.
3) And a positive urine culture of between 103 and 105 colony-forming units/ml with no more
than two species of microorganisms (Horan et al., 2008),
OR
1) The patient had an indwelling urinary catheter in place for >2 days and had it removed <48
hours before all elements of the criterion were first present together.
2) And at least one of the following signs or symptoms, with no other recognized cause(s): fever
>38°C; urgency; frequency; dysuria; suprapubic tenderness; costovertebral angle pain or
tenderness,
3) And a positive urinalysis with at least one of the following: a positive dipstick for leukocyte
esterase and/or nitrite; pyuria; microorganisms seen on Gram’s stain of unspun urine,
4) And a positive urine culture of between 103 and 105 colony-forming units/ml with no more
than two species of microorganisms (Horan et al., 2008).
The ABUTI criterion includes the following elements, all of which must occur within a
timeframe that does not exceed a gap of one calendar day between any two elements:
1) The patient has had an indwelling urinary catheter in place for >2 days and either still has it in
place or had it removed <48 hours before all elements of the criterion were first presented
together.
2) And a positive urine culture of ≥105 colony-forming units/ml with no more than two species of
uropathogen microorganisms.
3) And a positive blood culture matching at least one uropathogen microorganism to the urine
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culture, or at least two matching blood cultures drawn on separate occasions if the matching
pathogen is a common skin commensal (Horan et al., 2008).
Ventilator Associated Pneumonia
PNU1 represents clinically defined pneumonia (CDC, 2012). PNU1 requires at least one
of the following symptoms: fever (>38°C) with no other recognized cause; leukopenia (<4,000
white blood cells/mm3) or leukocytosis (>12,000 WBC/mm3); for patients >70 years old, altered
mental status with no other recognized cause. Additionally, at least two of the following
signs/symptoms must also be observed: changes in sputum characteristics, increased ventilator
requirements, or any other dysfunctional changes in the patients’ respiratory status (Peyrani,
2009).
PNU2 represents pneumonia with common bacterial or filamentous fungal pathogens and
specific laboratory findings, and viral, Legionella, and other bacterial pneumonias with definitive
laboratory findings (Peyrani, 2009). As discussed by Peyrani (2009), for pneumonia with
specific pathogens and laboratory findings, and a minimum of one required symptom such as:
fever (>38°C) ; leukopenia (<4,000 WBC/mm3) or leukocytosis (>12,000 WBC/mm3); mental
status changes for any patient older than 70 years of age.. In addition the criteria for PNU 1 must
be met as well. The following laboratory findings are also required as long as they are not
related to another source of infection, a positive blood or pleural fluid culture, a positive
quantitative culture from the lower respiratory track that is minimally contaminated, or a
microscopic test which reveals ≥5% BAL-obtained cells that contain intracellular bacteria from a
Gram stain. Furthermore, the histopathologic exam should reveal at least one of the following
evidences of pneumonia: abscess and/or consolidation within the bronchioles and alveoli which
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demonstrates PMN accumulation; quantitative cultures of lung parenchyma which contain fungal
or pseudohyphae elements (Peyrani, 2009).
For PNU2 for viral, Legionella, and other bacterial pneumonias with definitive laboratory
findings, only the laboratory criteria differ, the radiology and signs/symptom criteria are the
same as PNU2 for pneumonia with common bacterial or filamentous fungal pathogens and
specific laboratory findings (Peyrani, 2009). Definitive laboratory findings for Legionella, viral,
and other bacterial pneumonias must be met. The laboratory findings must include at least one of
the following:
positive culture of virus or Chlamydia from respiratory secretions; positive detection of
viral antigen or antibody from respiratory secretions; a fourfold rise in paired sera for
pathogen; positive PCR for Chlamydia or Mycoplasma; positive micro-IF test for
Chlamydia; positive culture or visualization by micro-IF of Legionella spp. from
respiratory secretions or tissue; detection of Legionella pneumophila serogroup 1
antigens in urine by RIA or EIA; fourfold rise in L. pneumophila serogroup 1 antibody
titer to ≥1:128 in paired acute and convalescent sera by indirect IFA. (Peyrani, 2009, p.
22-5)
According to Peyrani (2009) in the APIC Text, the PNU3 classification is reserved for
pneumonia in immunocompromised patients. In addition to the radiology criteria, the
signs/symptoms must include an immunocompromised patient who has at least one of the
following:
fever (>38°C) with no other recognized cause; leukopenia (<4,000 WBC/mm3) or
leukocytosis (>12,000 WBC/mm3); for patients >70 years old, altered mental status with
no other recognized cause; new onset of purulent sputum, or change in character of

136

sputum, or increased respiratory secretions, or increased suctioning requirements; new
onset or worsening cough, or dyspnea or tachypnea’s; rales or bronchial breath sounds;
worsening gas exchange, increased oxygen requirements, or increased ventilator demand;
hemoptysis; pleuritic chest pain. The laboratory findings must include at least one of the
following: matching positive blood and sputum cultures with candida spp.; evidence of
fungi or Pneumocystis carinii from minimally contaminated LRT specimen from either
direct microscopic exam or positive fungal culture. (Peyrani, 2009, p.22-5)
All of the pneumonia diagnostic criteria are listed in Table 1.
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Appendix B: CDC Flow Diagrams for Device –Associated Infections
The flow diagrams of device associated infections were guidelines set by the Centers for Disease Control and
Prevention to identify and classify healthcare associated infections.

Identification Central-line Bloodstream Infections (CLABSI)
Name:

MR#:

Admitting Diagnosis:

Admit Date:

Onset Date:

Culture Date:

†LABORATORY CONFIRMED BLOODSTREAM
INFECTION (LCBI): LCBI Criteria 1 and 2 may
be used for patients of any age, including patients
≤ 1 year of age

Unit:

DOB:

D/C Date:

M

Attending Physician:

# Bottles Positive:

Type of Line

Age:

Insertion
Date

Birth weight (gms) (Neonates
only): N/A
D/C Date

CL
Checklist
Completed

CRITERION- LCBI 1*:
Date
Recognized pathogen cultured from one or more
blood cultures
Central Line: An intravascular catheter that terminates at or
close to the heart or in one of the great vessels which is used for
infusion, withdrawal of blood, or hemodynamic monitoring.
CRITERION- LCBI 2*: (at least one of the following)
The following are considered great vessels for the purpose of
Date
reporting central-line BSI and counting central-line days in the
0
Fever (>38 C)
NHSN system:
Chills
- Aorta
- Pulmonary Artery
Hypotension
- Pulmonary Artery
- Superior Vena Cava
AND:
- Inferior Vena Cava
- Brachiocephalic Veins
Common skin contaminant (i.e. diptheroids
Internal
Jugular
Veins
Subclavian Veins
[Corynebacterium spp.], Bacillus spp. [not
External
Iliac
Veins
Common Iliac Veins
B.anthracis], Propionibacterium spp.,
coagulase-negative staphylococci [including S.
- Femoral veins
epi], viridans group streptococci, Aerococcus
spp., Micrococcus spp.) is cultured from two or
more blood cultures drawn on separate
NOTES:
occasions
NOTES:
AND organism cultured from blood is not
related to infection at another site





An introducer is considered an intravascular
catheter
Neither the insertion site nor the type of device
may be used to determine if a line qualifies as a
central line
Pacemaker wires & other nonlumened
devices inserted into central blood vessels or
the heart are not considered central lines,
because fluids are not infused, pushed nor
withdrawn through such devices

†LCBI Central Line (CL) or Umbilical Catheter UC)
was in place for >2 calendar days when all elements of
the LCBI infection criterion were first present together,
with the day of device placement being Day 1
*Criterion elements must occur within a timeframe
that does not exceed a gap of 1 calendar day

Adapted from CDC NHSN HAI information (CDC, 2015c)

F
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Identification of Catheter-Associated Urinary Tract Infection (CAUTI)

Adapted from CDC NHSN HAI information (CDC, 2015b)
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Identification of Ventilator Associated Pneumonia

Adapted from CDC NHSN HAI information (CDC, 2015d)

140

Appendix C: Data Use Agreement
The Data Use agreement for research purposes effective as of March 30, 2015 is entered
into by and between Doramarie Arocha and UT Southwestern Medical Center. The purpose of
this Agreement is to provide Data Recipient with access to a Limited Data Set (“LDS”) for use in
research in accord with the HIPAA and FERPA Regulations.
1.

Definitions. Unless otherwise specified in this Agreement, all capitalized terms used in this
Agreement not otherwise defined have the meaning established for purposes of the
“HIPAA Regulations” codified at Title 45 parts 160 through 164 of the United States Code
of Federal Regulations, as amended from time to time.

2.

Preparation of the LDS. UT Southwestern Medical Center shall prepare and furnish to
Data Recipient a LDS in accord with any applicable HIPAA or FERPA Regulations.

3.

Data Fields in the LDS. No direct identifiers such as names may be included in the
Limited Data Set (LDS). In preparing the LDS, UT Southwestern Medical Center shall
include the data fields specified as follows, which are the minimum necessary to
accomplish the research:
a.

Age, gender, race, ethnicity, microbiological laboratory positive cultures, severity
of illness which will be measured by chart review of each patients temperature,
mean arterial pressure, heart rate, respiratory rate, oxygenation, arterial pH, serum
potassium, serum sodium, serum creatinine, hematocrit, white blood cells and
count, coma score and chronic health problems.

b. All device associated healthcare infections patient list from three intensive care
units during 2010 through 2014 which includes demographics (age, gender,
ethnicity, and race), temperature, mean arterial pressure, heart rate, respiratory
rate, oxygenation, arterial pH, serum potassium, serum sodium, serum creatinine,
hematocrit, white blood cells count, coma score, age, and chronic health, and the
microorganisms causing the device-associated infections from TheraDoc and
EPIC software which include items listed above.
c. Personnel from the Informatics Department will provide the Limited Date Set
(LDS) requested above with unique patient identifier. Access of patient records
by the researcher will be limited to access rights as a student of Walden
University and must adhere to HIPAA guidelines.
4.

Responsibilities of Data Recipient. Data Recipient agrees to:
a. Use or disclose of the LDS only as permitted by this Agreement or as required by
law:
b. Use appropriate safeguards to prevent use or disclosure of the LDS other than as
permitted by this Agreement or required by law:
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c. Report to Data Provider any use or disclosure of the LDS of which it becomes
aware that is not permitted by this Agreement or required by law:
d. Require any of its subcontractors including the Informatics Department and the
Infection Preventionists that receive or have access to the LDS to agree to the
same restrictions and conditions on the use and/or disclosure of the LDS that
apply to Doramarie Arocha under this Agreement: and
e. Not use the information in the LDS to identify or contact the individuals who are
data subjects.
5.

Permitted Uses and Disclosures of the LDS. Data Recipient may use and/or disclose the
LDS for its Research activities only.

6.

Term and Termination.
a. Term. The term of this Agreement shall commence as of the Effective Date and
shall continue for so long as Data Recipient retains the LDS, unless sooner
terminated as set forth in this Agreement.
b. Termination by Data Recipient. Data Recipient may terminate this agreement at
any time by notifying the Data Provider and returning or destroying the LDS.
c. Termination by Data Provider. Data Provider may terminate this agreement at
any time by providing thirty (30) days prior written notice to Data Recipient.
d. For Breach. Data Provider shall provide written notice to Data Recipient within
ten (10) days of any determination that Data Recipient has breached a material
term of this Agreement. Data Provider shall afford Data Recipient an opportunity
to cure said alleged material breach upon mutually agreeable terms. Failure to
agree on mutually agreeable terms for cure within thirty (30) days shall be
grounds for the immediate termination of this Agreement by Data Provider.

7.

e. Effect of Termination. Sections 1, 4, 5, 6(e) and 7 of this Agreement shall survive
any termination of this Agreement under subsections c or d.
Miscellaneous.
a. Change in Law. The parties agree to negotiate in good faith to amend this
Agreement to comport with changes in federal law that materially alter either or
both parties’ obligations under this Agreement. Provided however, that if the
parties are unable to agree to mutually acceptable amendment(s) by the
compliance date of the change in applicable law or regulations, either Party may
terminate this Agreement as provided in section 6.
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b.

Construction of Terms. The terms of this Agreement shall be construed to give
effect to applicable federal interpretative guidance regarding the HIPAA
Regulations.

c.

No Third Party Beneficiaries. Nothing in this Agreement shall confer upon any
person other than the parties and their respective successors or assigns, any
rights, remedies, obligations, or liabilities whatsoever.
Counterparts. This Agreement may be executed in one or more counterparts,
each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.

d.

e.

Headings. The headings and other captions in this Agreement are for
convenience and reference only and shall not be used in interpreting, construing
or enforcing any of the provisions of this Agreement.

IN WITNESS WHEREOF, each of the undersigned has caused this Agreement to be duly
executed in its name and on its behalf.
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Appendix D: Infection Numbers & Incidence Rates per 1000 Days for Each of the Three ICUs
2010-2015
CVICU

CLABSI

2010
2011
2012
2013
2014
TOTAL
RATE

6
8
2
3
5
24
1.1

MSICU

CLABSI

2010
2011
2012
2013
2014
TOTAL
RATE

3
6
4
9
8
30
1.1

NSICU

CLABSI

2010
2011
2012
2013
2014
TOTAL
RATE

0
3
0
4
0
7
0.6

CL
Days
3842
4352
4120
4339
4303
20956

CL
Days
4636
5596
5304
6053
5188
26777

CL
Days
2684
2794
2392
2059
1468
11397

Rate

CAUTI

1.56
1.84
0.49
0.69
1.16
1.15

10
15
10
6
4
45
2.9

Rate

CAUTI

0.65
1.07
0.75
1.49
1.54
1.12

23
25
16
14
9
87
4.1

Rate

CAUTI

0.00
1.07
0.00
1.94
0.00
0.61

13
18
18
14
9
72
4

F/C
Days
3090
3245
3153
3331
2738
15557

F/C
Days
4483
5009
4240
4161
3527
21420

F/C
Days
3788
4126
3922
3512
2830
18178

Rate

VAP

3.24
4.62
3.17
1.80
1.46
2.89

8
1
1
2
1
13
1.4

Rate

VAP

5.13
4.99
3.77
3.36
2.55
4.06

6
2
0
2
3
13
0.95

Rate

VAP

3.43
4.36
4.59
3.99
3.18
3.96

12
6
2
6
2
28
4.6

Pearson Correlation Coefficients (P-value)
CVICU
MSICU
0.237
0.158
CLABSI Rate
(0.395)
(0.574)
-0.477
0.254
CAUTI Rate
(0.073)
(0.360)
-0.26
-0.358
VAP Rate
(0.349)
(0.190)
* Statistically significant at p < 0.05

Vent
Days
1941
1804
1968
2021
1798
9532

Vent
Days
2456
2623
2623
3283
2742
13727

Vent
Days
1150
1212
1237
1268
1284
6151

NSICU
-0.395
(0.145)
0.222
(0.426)
0.618
(0.014)*

Rate
4.12
0.55
0.51
0.99
0.56
1.36

Rate
2.44
0.76
0.00
0.61
1.09
0.95

Rate
10.43
4.95
1.62
4.73
1.56
4.55
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Appendix E: ICU SIR Ratios and Utilization Rates

TYPE OF
LOCATION
MSICU

SIR – HOSPITAL CLABSI RATE TABLE FOR ICU 2010-2014
#
CLABSI Rate NHSN Rate
#
EXPECTED
CENTRAL
per 1000 CL
per 1000
CLABSI
# of CLABSI
LINE-Days
Days
CL Days
30
26777
1.1
1.1
29.5

INDIVIDUAL
SIR
1.0

CVICU

24

20956

1.1

0.8

16.8

1.4

NSICU

7

11397

0.6

0.9

10.3

0.7

TOTAL

61

59130

1.0

56.48

Benchmark from NHSN Data Summary 2013 (Issued 2015)
p value = 0.136

TYPE OF
LOCATION
MSICU
CVICU
NSICU

SIR = 1.08

SIR – HOSPITAL CAUTI RATE TABLE FOR ICU 2010-2014
CAUTI
# FOLEY
NHSN Rate
#
Rate per
EXPECTED
CATHETER
per 1000
CAUTI
1000 Foley
# of CAUTI
DAYS
Foley days
Days
87
21420
4.1
2.7
57.8
45
15557
2.9
1.8
28
72
18178
3.9
5.3
96.3

204
55155
3.7
TOTAL
Benchmark from NHSN Data Summary 2013 (Issued 2015)
p value = 0.027 significant for NSICU

INDIVIDUAL
SIR
1.5
1.6
0.7

182.18
SIR = 1.12

SIR – HOSPITAL VAP RATE TABLE FOR ICU 2010-2014
TYPE OF
LOCATIO
N

#
VAP

#
VENTILATOR
DAYS

VAP RATE
per 1000
Vent Days

MSICU
CVICU
NSICU

13
13
28

13727
9352
6151

0.95
1.4
4.6

TOTAL

54

29230

1.8

NHSN
RATE per
1000 Vent
days
1.6
1.7
2.1

EXPECTED
# of VAP

INDIVIDUAL
SIR

22
15.9
12.9

0.5
0.8
2.2

50.78

Benchmark from NHSN Data Summary 2013 (Issued 2015)
p value = 0.096

SIR = 1.06
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ICU Utilization Rates
DEVICE UTILIZATION RATE
2010-2014
0.90
CVICU
0.80

MSICU
ZLICU

0.70

RATE

0.60
0.50
0.40
0.30
0.20
0.10
0.00
CENTRAL LINE

FOLEY CATH
TYPE OF DEVICE

VENTILATOR
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Appendix F: Distribution of Organisms (%) by ICU and MDRO Status
Distribution of Organisms (%) by ICU based on MDRO Status

Microorganism
GNR
GPC
YST
TOTAL

CVICU
40.00%
60.00%
0.00%
100.00%

ICU
Type
MSICU
44.00%
56.00%
0.00%
100.00%

GNR
GPC
YST
TOTAL
chi-squared test performed
* Statistically significant at p < 0.05

44.78%
19.40%
35.82%
100.00%

47.42%
11.34%
41.24%
100.00%

MDRO
X 2 = 1.524
p = 0.467
NonMDRO
X 2 = 34.397
p < 0.001*

NSICU TOTAL
16.67% 38.89%
83.33% 61.11%
0.00%
0.00%
100.00% 100.00%
78.65% 57.71%
14.61% 14.62%
6.74%
27.67%
100.00% 100.00%

Distribution of Organisms (%) by HAI Type based on MDRO Status

Microorganism
GNR
GPC
YST
TOTAL
Non-MDRO
GNR
X 2 = 39.247
GPC
p < 0.001*
YST
TOTAL
* Statistically significant at p < 0.05
MDRO
X 2 = 2.731
p = 0.255

CAUTI
55.56%
44.44%
0.00%
100.00%
61.86%
8.25%
29.90%
100.01%

HAI Type
CLABSI
26.32%
73.68%
0.00%
100.00%
29.27%
41.46%
29.27%
100.00%

VAP
50.00%
50.00%
0.00%
100.00%
77.78%
22.22%
0.00%
100.00%

TOTAL
38.89%
61.11%
0.00%
100.00%
57.71%
14.62%
27.67%
100.00%

